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Abstract 
Cyclophel l i to l 1，isolated f rom the culture filtrates of a mushroom, 
Phellinus sp” has been synthesized f rom (-)-quinic acid in an enantiospecific 
fashion. In addi t ion, the unnatural (17^,65)-, ( 25> , and (1/?,25,65)-
diastereoisomers of cyclophell i tol 2，3，and 4 as wel l as the epoxy analogues 
104 and 105 have been prepared via this strategy. The synthesis of 1-4 and 
104 employed the Shaipless protocol to fo rm the key intermediate, the cyclic 
sulfate 70. This cyclic sulfate 70 was converted into the allyl ic alcohol 54 via 
regioselective substitution and elimination reactions. The p-allylic alcohol 53 
had been obtained by the Mitsunobu reaction of 54. Hydroxy-directed or 
steric-controlled M C P B A epoxidation of the al lyl ic alcohols 53 and 54 gave 
cyclophell i tol and its diastereoisomers 1-4 after deprotection. Stereoselective 
synthesis of the epoxy analogue 104 was achieved by base treatment of the 
iodo alcohol 7 1 fo l lowed by debenzylation. The epoxy analogue 105 was 
obtained via Corey-Winter deoxygenation, epoxidation and debenzylation 
reactions of the diol 57. Structure-function studies of the above compounds 
were discussed base on the the results of biological assays on glycosidases. 
iii 
Abbreviations 
Ac acetyl J coupling constant 
Bn benzyl M moles per liter 
Bzl benzoyl MCPBA m-chloroperoxybenoic acid 
b.p. boiling point miz mass to charge ratio 
"Bu "-butyl Me methyl 
:Bu fm-butyl min minute(s) 
c concentration mmol millimole(s) 
° C degrees Celsius mol mole(s) 
calcd calculated m.p. melting point 
CI chemical ionization MS mass spectrometry 
conc. concentrated Ms methanesulfonyl 
DBU 1,8-diazabicyclo[5.4.0]undec- NMR nuclear magnetic resonance 
7-ene PCC pyridinium chlorochromate 
DEIPS diethyHsopropyl silyl Ph phenyl 
DIAD diisopropyl azodicarboxylate Pr propyl 
DIBAL-H diisobutylaluminum hydride 'Pr w^-propyl 
DMAP 4-(dimethylamino)pyridine r.t. room temperature 
DMF dimethylformamide TBDMS re/t-butyldimethylsilyl 
DMSO methyl sulfoxide TEA triethylamine 
EI electron impact TFA trifluoroacetic acid 
FT fourier transform THF tetrahydrofuran 
g gram(s) TLC thin layer chromatography 
h hour(s) TMS trimethyl silyl or tetramethyl 
Hz hertz silane 
IR infrared 
iv 
I In t roduct ion 
I - l General Background 
Cyclophemtol[(15;2/?，3S，4A5i?，6/?)-5-hydix)xymethyl-7-oxabicyclo[4.1.0]heptane_ 
2,3,4-triol] 1 was isolated from the culture filtrates of a mushroom, Phellinus sp” by 
Umezama et al in 1989.1 The absolute configuration of cyclophellitol 1 was 
established by X-ray crystallographic analysis which disclosed a fully oxygenated 
cyclohexane corresponding to a carba analogue of D-glucopyranose.^ 
H O — ^ 
H〇m“々 ^Y 
H C ^ ^ O H 
cyclophellitol 
1 
Cyclophellitol 1 was found to inhibit 50% of the almond p-D-glucosidase 
activity at a concentration of 0.8 [ig/miA The value is lower than the IC-ost of 1-
deoxynojirimycin (30 |ig/ml) and of castanospermine (12 |LLg/ml). Also it showed no 
antimicrobial activity and no cytotoxicity on NIH 3T3 cells, Molt-4 cells, and P388 
cells at 100 ^g/ml.^'^ 
Structurally, cyclophellitol 1 is a unique pseudo-pyranose with a p-epoxide 
moiety. The epoxide, the three hydroxy groups and the hydroxymethyl group in 1 
have the configuration of p-D-glucose. Since cyclophellitol, a p-D-glucosidase 
inhibitor, has a p-epoxide, the a-epoxide 2 might be an a-D-glucosidase inhibitor. 
Along this vein, the unnatural diastereoisomeric epoxides 3 and 4 which are 
structurally related to p-D-mannose and a-D-mannose respectively (Fig.l) might be 
potential inhibitors of the corresponding glycosidases. 
卞 The IC50 value reflects the amount of compound required for 50% inhibition of the enzyme under the 
standard assay conditions. 
1 
H O " " V 〇 H O - y ^ HO-u 
H O n - ^ \ . . . O H 
HO 'BH H C / " \ H H O ^ O H 
p-D-glucose a-D-glucose p-D-mannose a-D-mannose 
^^^ H O - M H O - M H O - M 
H O n . . / ^ ^ H O n . . / ^ ^ H O n - T ^ ^ ^ 
HO OH HO OH H O ^ C D H H C F L D H 
cyclophellitol 
1 2 3 4 
Fig. 1 Relationship between sugars and potential cyclohexane oxide inhibitors 
of glycosidases. 
The syntheses of cyclophellitol 1 and its {1R,6S)-, (25)-, and (1/?,25,65)-
diastereoisomers 2’ 3，and 4 may help to clarify their mode of action in glycosidase 
inhibition. Furthermore, these compounds have the potential of inhibiting Human 
Immunodeficiency Virus (HIV)—the etiologic agent of the Acquired Immune 
Deficiency Syndrome (AIDS) since several glycosidase inhibitors had already shown to 
display antiviral activities.^"^ 
1-2 Review on Epoxycyclohexanes 
Recently, there has been increased interest in the synthesis of 
epoxycyclohexanes such as cyclophellitol 1,6-12 conduritol epoxides 5，i3-i7 
crotepoxide 718-22 and their analogues. This class of compounds exhibits interesting 
biological properties including glycosidase-inhibitory, tumour-inhibitory, antileukaemic 
and antibiotic activities.丄’ 2’ 23，24 
Conduritol epoxides (1,2-anhydroinositols) 5 are derivatives of conduritols 
2 
623-25 (there are ten stereoisomers: the achiral A and D, and the chiral B, C, E，F and 
their enantiomers) which are useful synthetic intermediates as well as glycosidase 
inhibitors. Conduritol epoxides 5 having a configuration of their hydroxy groups 
corresponding to that of the substrate glycose residue are potential active site- directed 
inhibitors for glycohydrolases.^ Structurally, conduritol epoxides can be compared 
with cyclophellitol 1. Conduritol B epoxide (l,2-anhydro-m};c?-inositol), the first 
reported site-directed irreversible inhibitor，14 structurally resembles that of 1 except that 
it lacks the C-5 hydroxymethyl group of a true pseudo-hexose. Several conduritol 
epoxides had been synthesized (Conduritols B，i4-i7 q24 e，i3 ^nd F : ” and their 
biological assays gave some insight to the mechanism of glycosidase 
inhibition. 14，24’ 26 
OH OH 
A S ^ O H 人 OH 
丫 I ^ ^ y ^ A: 1a，2p，3p, 4a 
^ J k I JL B: 1a, 2P, 3a，4p 丫 〇H Y ^ O H C: 1a, 2a, 3a, 4p 
OH OH D: 1a, 2a, 3a, 4a 
E: 1a, 2a, 3p’4p 
conduritol epoxide conduritol F: 1a, 2a, 3p, 4a 
5 6 
Crotepoxide 7, senepoxide 10，and pipoxide 9 were discovered during the 
period 1968-1970 from Cron macrostachys》、28 Uvaria catocarpaP and Piper 
hookerfiQ respectively. These compounds exhibit biological properties including 
tumour-inhibitory, antileukaemic and antibiotic activities. 23 Crotepoxide 7 and the 
newly discovered boesenoxide are members of a group of naturally occuring highly 
oxygenated cyclohexane derivatives which possess the diepoxide functionality. In 
1984，two new epoxides p-senepoxide 11 and tingtanoxide 12 were isolated from 
Uvariaferruginea A review of these compounds has been reported by Balci^ and 
by Thebtaranonth.33 
3 
O ^CHsOBzl pHzOBzl •〇 
’ X ^ O A c 1 > ^ 0 A c <^|.、、、CH2〇BzI 
crotepoxide 7 boesenoxide 8 pipoxide 9 
^^ .xCH^OBZI ^<|^CH2〇BZI 
T ^ O A C V ^ O A C 认 AC 
OAc OAc OBzl 
senepoxide 10 p-senepoxide 11 tingtanoxide 12 
In 1989, a series of novel epoxycyclohexanes 13-16 were isolated from the 
culture filtrate of the fungus Eutypa lata during the search for pathogenetically active 
secondary metabolites. 34’ 35 j h e absolute configuration of eutypoxide B 14 was 
confirmed by a recent synthesis reported by Takano.^^ 
OH 人 OH O 









1-3 Mechanistic Aspect of Glycosidase Inhibitors 
1-3-1 General Background 
Glycosidases are key enzymes in the biosynthesis ofiV-linked glycoproteins 
because they play a critical role in the formation of iV-linked oligosaccharides 
[consisting of high mannose, complex, and hybrid structures, all of which arise from 
processing of the common precursor, Glu3Man9(GlcNAc)2]. A l l A^-linked 
oligosaccharides are initially assembled in the endoplasmic reticulum by the stepwise 
addition of various sugars to the lipid carrier, dolichyl-P, to form the oligosaccharide 
donor，Glu3Man9(GlcNAc)2-PP-dolichol. The oligosaccharide is then transferred to 
specific asparagine residues on the polypeptide chain as the protein is being synthesized 
on membrane-bound polysomes.�？ 
Because glycosidases are involved in many areas of metabolism and turnover, 
inhibitors of these enzymes could have many kinds of beneficial effects as therapeutic 
agents. That is, they could be useful as antihyperglycemic agents, as inhibitors of 
tumour metastasis or viral replication, as drugs to prevent obesity, as antifugal agents 
or as agents to interfere with insect feeding. In addition, these inhibitors are potentially 
valuable tools to study the mechanism of these enzymes as well as their role in cell 
function. Thus, inhibition of glycoprotein-processing enzymes have been widely used 
in cell culture systems to determine the role of specific oligosaccharide structures in 
glycoprotein function.37 
Two major types of glycosidases occur in the endoplasmic recticulum and the 
Golgi body. They are the glucosidases and mannosidases which are further specified 
according to their action on the oligosaccharide. For example, glucosidase I removes 
the outermost al,2-linked glucose of Glc3Man9(GlcNAc)2~~protein to produce a 
Glc2Man9(GlcNAc)2prote in . Other glycosidases found are glucosidase II, 
mannosidase I and II，ER a-mannosidase, and endomannosidase.^^ 
Since the envelope glycoprotein of HIV is heavily glycosylated, it seems 
plausible that inhibitors of one of the enzymes required for processing glycoproteins 
5 
may prevent envelope formation and affect virus infectivity. For example, the 
glucosidase inhibitors castanospermine and deoxynojirimycin exhibit activity against 
this virus.3，4 Glycosidase inhibitors appear to work by preventing the processing of 
AMinked complex oligosaccharides. This results in the disruption of synthesis of viral 
coat glycoprotein, such as glycoprotein 120 (gpl20) and is believed to be the specific 
primary mode of action of trimming glycosidase inhibitors in HIY. The disruption of 
gpl20 formation results in loss of recognition by the CD-4 receptor in syncytia 
formation with consequential reduction in virus infectivity and inhibition of viral 
replication.^^ 
1-3-2 Acid-catalyzed Hydrolysis of Glycosides 
Hydrolysis of glycosidases occurs by cleavage of the bond between the 
anomeric carbon and the glycosidic oxygen atom. These reactions are thus a 
nucleophilic substitution at C一 1. Direct displacement of the aglycon by hydroxide or a 
water molecule in an 8^2 reaction is strongly hindered，because it would require an 
inversion at the anomeric carbon atom. This would result in an intermediate having an 
unfavourable skew or boat conformation, making the activation energy prohibitively 
high.24 
H3O+ H2O 
仏 。 、 R ^ 工 u + -
外 O 
H30+ H20 
• O H — 
I 
H 
Fig. 2 Acid-catalyzed Hydrolysis of p-Glycoside (Hydroxy substituents omitted). 
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An SNI reaction, on the other hand, is much more favourable, because the 
glycosyl cation intermediate is stabilized by charge distribution between the C - 1 and 
the ring oxygen atom. The unfavourable formation of an ion-pair on bond cleavage can 
be avoided by protonation of the glycosidic oxygen atom and thus the requirement for 
acid catalysis (Fig. 2).以 
1-3-3 Enzyme-catalyzed Hydrolysis of Glycosides 
Glycosidase-catalyzed hydrolysis resembles the acid-catalyzed hydrolysis of 
glycosides in that cleavage of the glycosyl (Ci一oxygen) bond occurs. Most 
mechanistic data come from enzymes that catalyze the reaction with retention of the 
anomeric configuration; that is, reaction in which the glycosyl donor and product have 
the same anomeric form. The enzyme reactions commonly proceed through a discrete 
glycosyl-enzyme intermediate. Two significant amino acid groups are generally 
involved: a carboxylate that stabilizes the glycosyl-enzyme and an amino acid that 
serves as a general acid catalyst to protonate the glycosidic oxygen.39 
A general mechanism consistent with many of the data is shown in Fig. 3 (a 
hypothetical p-glucosidase that cleaves a p-glycoside bond and liberates p-D-glucose). 
The carboxylate anion can participate in two ways, by electrostatic stabilization of the 
developing oxocarbonium ion (upper pathway. Fig. 3) or by covalent nucleophilic 
attack of the reaction centre (lower pathway. Fig. 3). Unless an acceptor rapidly traps 
the glycosyl cation, the potential to collapse to the covalent form is great given the short 
ion distances and extremely brief lifetime of the oxocarbonium ion. When a covalent 
complex thus form, either by direct nucleophilic attack or via an oxocarbonium ion, the 
reaction reduces to a typical double displacement mechanism involving two sequential 
anomeric inversions. The much greater stability of the covalent complex would bias the 
equilibrium in that direction, but the actual productive form of the transition state in 
transfer of the glycosyl intermediate to an acceptor cannot be generalized; both 
7 
noncovalent and covalent mechanisms are relevant.^^ 
/ / / / / / / / / / / / 
A-
/ /////)////// 
/ / / / 《 / / / / / / / / / / / / / / / / / / 
A A 
O 令 o 
/ / / / / ) / / / / / / 7777777/7/77 
\ / / / / / / / / / / / / . 
2 \ ^ ^ / t 
0丫0 
77777/777/77 
Fig. 3 Reaction intermediates of a hypothetical p-glucosidase proceeding 
with retention anomeric configuration. The upper pathway passes through 
an oxocarbonium ion transition state and the lower pathway passes through a 
covalent a-glucosyl intermediate (Hydroxy substituents omitted). 
1-3-4 Types of Inhibitors^^ 
Inhibition are usually classified as reversible or irreversible, competitive or 
noncompetitive according to their modes of action on the enzymes. In irreversible 
inhibition, the inhibitor is covalently linked to the enzyme or bound so tightly that its 
dissociation from the enzyme is very slow. In contrast, reversible inhibition is 
characterized by a rapid equilibrium of the inhibitor and enzyme. Reversible inhibitors 
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have been particularly valuable in confirming a transition-state structure and exploring 
the active site environment, and irreversible inhibitors have been useful in mechanistic 
studies and identification of active site functional amino acids.恥 
A competitive inhibitor resembles the substrate and binds to the active site of the 
enzyme. The substrate is then prevented from binding to the same active site (Fig. 4). 
A competitive inhibitor diminishes the rate of catalysis by reducing the proportion of 
enzyme molecules that have a bound substrate. In noncompetitive inhibition, the 
inhibitor can bind simultaneously to an enzyme molecule. This means that their binding 
sites do not overlap. A noncompetitive inhibitor acts by decreasing the turnover 
number^ of an enzyme rather than by diminishing the proportion of enzyme molecule 
• * 
that have bound to substrate. By kinetic studies, competitive and noncompetitve 
inhibition can be distinguished by the Lineweaver-Burk plot."^ 
Competitive 
Substrate i n h i b i t o r 、 Substrate 
T / " ^ \ / ^ N Non competitive T 
(^Enzyme ) Enzyme J C Enzyme ) 
Fig. 4 Distinction between a competitive inhibitor and a noncompetitive inhibitor: (left) 
enzyme-substrate complex; (middle) a competitive inhibitor prevents the substrate from 
bi l l ing; (right) a noncompetitive inhibitor does not prevent the substrate from binding. 
Cyclophellitol has been identified as an irreversible competitive inhibitor of p-D-
glucosidase.^' 41 In order to have a general idea of the mechanistic aspect, the well 
established mechanisms of conduritol epoxides wil l be discussed in the next Section. 
§ turnover number is defined as the number of moles of substrate transformed per minute per mole of 
enzyme (units per micromole of enzyme) under optimum conditions. 
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1-3-5 Inhib i t ion of glycosidases by conduritol epoxides 
Among the conduritol epoxides, conduritol B，C，and F epoxides are best 
studied.24, 26’ 39, 42 Conduritol epoxides are derived from inositol isomers, where, for 
example, conduritol B epoxide approximates the glucose hydroxy orientation, 
conduritol C epoxide approximates galactose, and conduritol F epoxide approximates 
mannose. In addition, specificity can be dictated by the epoxide group, which can be 
oriented on either face of the pyranose ring; enzyme inactivation commonly occurs only 
with epoxide alignment consistent with the enzyme anomeric specificity (see Table 
1).24 For example, conduritol C trans-cpoxidt is a specific inhibitor of a-D-
galactosidase while its cw-isomer is an inhibitor of p-D-galactosidase only. 
OH OH OH 
。、、、.r^。H ^ . - O H A ^ O H 
〇)". 〇 （ ] O t f T 
Y ' " o h ^ Y ^ h 
OH OH OH 
conduritol B epoxide conduritol C frans-epoxide conduritol F trans-epox\6e 
17 18 20 
OH OH 
o ( 〕 o r C j 
OH OH 
conduritol C c/s-epoxide conduritol F c/s-epoxide 
19 21 
The reactivity of the epoxide group in a tetrahydroxycyclohexane system against 
acid-catalyzed and nucleophilic addition is greatly diminished by the electron-
withdrawing effect of the neighboring hydroxy groups. 24 Conduritol epoxides are 
quite stable near neutral pH but become highly reactive on proton transfer to the 
epoxide oxygen. The glycosidase inhibition mechanism, when successful, proceeds by 
protonation from the active site with general acid and capture by a nucleophile for the 
10 
formation of the covalent bond. In most cases, the nucleophile is the carboxylate group 
of aspartate or glutamate.24 
enzyme D-glucosidase D-galactosidase D-mannosidase 
inhibitor a- p- a- p- ” ^ ~ ^ 
conduritol B epoxide V V 
conduritol C _ s - e p o x i d e J^ 
conduritol C c/s-epoxide ^ 
conduritol F fra/?s-epoxide ^ 
conduritol F c/s-epoxide ^ 
Table 1 Specific inhibition of glycosidases by conduritol epoxides. 
Racemic conduritol B epoxide was first synthesized and tested against p-D-
glucosidase by Gero43 and Legler"^^ et al p-D-glucosidase discriminates between the 
two enantiomers, only the D-enantiomer is an inhibitor of p-D-glucosidase, giving rise 
to (+)-c/n>(9-inositol 22 after release by hydroxy amine from the enzyme (Scheme 1， 
upper reaction). The L-enantiomer inhibits neither p- nor a-D-glucosidase. Due to the 
symmetry of conduritol B epoxide, a simple inversion of the structure converts the 
inhibitor from a derivative with the epoxide oxygen pointing down, and all the hydroxy 
groups equatorial to one with the epoxide up, and all the hydroxy groups equatorial. 
As shown in Table 1，conduritol B epoxide is also an a-D-glucosidase inhibitor which 
gave ^cy//<9-inositol 23 after released from the enzyme (Scheme 1，lower reaction). 
The opening of the epoxide ring catalyzed by a-D-glucosidase does not follow the rule 
of Fiirst and Plattner for the normal trans-diaxial epoxide ring opening.45 Kinetic 
studies showed that conduritol B epoxide reacts with p-D-glucosidase 50 to 200 times 
more rapidly than a-D-glucosidase. This difference may be attributed to the 
unfavorable ring opening enforced by the geometry and orientation of the catalytic 
groups at the active site o f a-D-glucosidase.^"^' 42 
11 
^ ^ ^ l u i i m i 
HA OH 厂 ？H 
_ X：：：：^^  H O , , ^ O H 
TTmhm rnifmr 〇h 
(+)-c/7//-o-inositol 22 
L^m^ I i i i n i i i i 
K Q A O 9H 
HA A- HO、、、.^j^、〇H 
11111)1111 1111)1111 OH 
sc>V/0"inositol 23 
Scheme 1 Reaction of condmitol B epoxide (hydroxy groups omitted) with p_ and a-
D-glucosidase and release from hydroxyamine to form (+)-c/2/r(9-inositol 22 and scyllo-
inositol 23 respectively. 
1-4 Previous Synthesis of cyclophellitol and its diastereoisomers 1-4 
Since the isolation of cyclophellitol 1 in 1989，two enantiospecific and one 
racemic syntheses have appeared.^ , 7, 9,11 Also, the (l/?,65)- and (1/?,25,65)-
diastereoisomers 2 and 4 have been synthesized via a nitrile oxide 
cycloaddition.io’ n，12 
1-4-1 Synthesis of cyclophellitol 1 via nitr i le oxide cycloaddition^' n 
The first synthesis of cyclophellitol 1 was conducted by the same Japanese 
group who did the isolation.^' n The synthesis is shown in Scheme 2 using an 
expensive unnatural sugar, L-glucose, as starting material. L-xy/o-Hex-5-
enopyranoside 25 was formed f rom L-glucose in four steps fo l lowing the procedures 
of Gero et al^^ and Liptak et al，，Chain extension was performed on 25 using 
12 
stereoselective hydroboration, oxidation and Wittig reactions to give the olefin 26. The 
key intermediate, oxime 27 was produced by treating the compound formed from 
acidic hydrolysis of 26 with hydroxy amine. Intramolecular cycloaddition of 27 via 
the intermediary nitrile oxide to afford the isoxazoline 28 as a single adduct. The 
isoxazoline 28 was opened using H〗and Raney-Ni to form a keto-diol in which 
广OH ^ 
丨 O A y x O B n v-vn 
H O ^ Y ^ O H M e O ^ ^ S ^ O B n M e O ^ ^ ^ ^ O B n 
〇H OBn OBn 
L-glucose 24 2 5 2 6 
OH OH 
vm - IX ^ ^ X / \ ) xi - xiii 
OH OBn OBn 
2 7 2 8 
DEIPSO DEIPSO 
DEIPS0Z""'.h.、、、0Bn xiv-xvi ^ DEIPSO^'''..^.、、、。" xvii ^ ^ 
= O 
OBn 
2 9 3 0 
Scheme 2 
Scheme 2 Reagents and conditions: i. HCl, MeOH; ii. PPh3, 12, imidazole, toluene， 
reflux; i i i . NaH, DMF, 0 then BnBr; iv. AgF, pyridine, room temp (80%); v. 
dicyclohexylborane, THF, 25。C，1.5 h then H^O�，NaOH，50。C，20 min (85%); vi. 
(C0C1)2，DMSO, TEA, CH2CI2, 一 78。C; vii. PhgP-CH�，PhH, room temp (75% 
from xiv); vi i i . HCl, aq. dioxane, 80。C; ix. NH20H*HC1, pyridine, room temp (80%); 
X. NaOCl，CH2CI2 (70%); xi. Raney Ni，H2, AcOH, aq. dioxane, 25。C，1.5 h (80%); 
xii. 2，6-lutidine，DEIPSCl, CH2CI2, 0。C (90%); xii i. BHg.MesS，THF, 25。C，12 h 
(80%, a : p = 1 : 3); xiv. MsCl, pyridine, 25。C，1 h (75%); xv. H�，Pd(0H)2，MeOH; 
xvi. NaOMe, CHCI3, 0。C，10 min; xvii. "Bi^NF, THF, 25。C，10 min (40% from 
XV). 
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the hydroxy groups was then protected and the ketone moiety was reduced to give 2 9 
as the major product (a : p = 1 : 3). Mesylation of 29 followed by hydrogenolysis 
gave a triol which with sodium methoxide gave the protected cyclophellitol 30. 
Deprotection of 30 afforded cyclophellitol 1 in 17 steps with an overall yield of 1.7%. 
1-4-2 Synthesis of cyclophellitol 1 from L-quebrachi tol^ 
The second approach demonstrates the versatility of L-quebrachitol 31 as a 
homochiral starting material by Ozaki's group.? As shown in Scheme 3，protection of 
L-quebrachitol 31 followed by oxidation of the free hydroxy group gave the ketone 32. 
Peterson olefination of 32 gave an exo-oltfin which was then hydroborated and 
protected as its benzoate 33 (a : p = 1 : 1). Chemoselective demethylation of the 
methyl ether 33 in preference to the cis cyclohexylidene moiety was accomplished by 
the action of AICI3 and "BU4NI to give the triol 34.48 Benzylation of 34 followed by 
acidic hydrolysis of the cis cyclohexylidene moiety gave the diol 35. Selective 
triflation of the equatorial hydroxy group in 35 followed by acetylation of the 
remaining hydroxy group gave 36. 5^2 displacement of the triflate by iodide followed 
by base treatment gave the protected cyclophellitol 37. Deprotection of the benzyl 
groups completed the synthesis of cyclophellitol 1 in 13 steps with an overall yield of 
9.7%. 
14 
0CH3 � 3 BZIO OCH3 
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L-quebrachito丨 31 3 2 3 3 
BzIO OH 
I I OBn OBn 
'"r^^..、、〇H I f 
V' 1 V''. viii ix, x 
“ o 、 、 、 . ^ v ^ o H “ [ r ^ 
( _ } 知 
3 4 3 5 
f n OBn OBn OBn 
OTf 〇、 
3 6 3 7 
Scheme 3 
Scheme 3 Reagents and conditions: i. cyclohexanone, PhH, reflux (72%); ii. kojd, 
DMSO，CH2CI2, reflux 8 h (100%); iii. MegSiCHsMgCl，THF, room temp, 9 h then 
KH, THF, room temp, 3 h; iv. BH3.THF, room temp, 1 h then H2O2, NaOH, 50 
Ih; V. BzlCl, pyridine (67% from i i i ” a : p= 1 : 1); vi. AICI3 (10 eq), ” BU4NI (10 eq), 
CH3CN, room temp, 12 h (63%); vii. BnBr, NaH, NaOMe, DMF, room teiiip, (85%); 
viii. TFA, MeOH, room temp, 2 h (90%); ix. (CFsSO〗)!。’ pyridine, 0。C，1 h (98%); 
X. AC2O，pyridine, room temp, overnight (95%); xi. "BU4NI，PhH, reflux, 6 h (96%); 
xii. NaOMe, THF-MeOH, room temp，1 h (93%); xiii. 10% Pd-C, H〗，MeOH, room 
temp, overnight. 
1-4-3 Racemic Synthesis of cyclophellitol 1 via a Diels-Alder Reaction^ 
A racemic synthesis was reported by Vogel et al^ using a Lewis acid catalyzed 
Diels-Alder reaction for the formation of the cyclohexane ring skeleton. As shown in 
Scheme 4，the £nJ<9-adduct 40 was obtained from furan 38 and 1-cyanovinyl acetate 
39. Saponification of 40 in the presence of formalin afforded a unsaturated ketone 
15 
which was protected as the dibenzyl acetal followed by epoxidation to give an exo-
epoxide 41. In the presence of HSO3F, the epoxide in 41 was opened by Im-
migration of the endo-h^nzyl group to form a keto-alcohol which was protected as its 
silyl ether 42. Aldol reaction of the silyl enol ether from 42 with formaldehyde gave 
an 以o-product 43. The keto group in 43 was reduced with sodium borohydride to 
give an endo-dlcoho\ which was treated with HBr/AcOH to give the bromocyclohexane 
derivative 44. Racemic cyclophellitol (土 ) - l was furnished by treatment of 44 wi th 
sodium methoxide. 
。 + 人 — j ^ C N 么 0 ^ 0 . 
OAc OBn 
3 8 3 9 4 0 4 1 
〇 O 
v ’ v i vii, viii ^ I V ^ O 
T B D M S Q ^ ^ ^ ^ T B D M S C ^ J C ^ O H 
OBn OBn 





Scheme 4 Reagents and conditions: i. Cu(0Ac)2 (cat.), Cu(BF4)2 (cat.), 31。C，5 d 
(<37%); i i . NaOMe, MeOH, then formalin (93%); i i i . TMSOBn, TMSOTf (cat.) 
(86%); iv. MCPBA, CHCI3, 20。C，3 h (93%); v. HSO3F, BnOH, CH2CI2 (87%); vi. 
TBDMSCl, imidazole, DMF (82%); vii. (MegSi)〕—，TBDMSCl, THF, - 78。C 
(87%); vii i . H2CO, CH2CI2, - 78 then TiCl*，2 h (89%); ix. NaBH*，MeOH, 0 
(95%); X. 30% HBr/ AcOH, 60。C，20 h (69%); xi. NaOMe, MeOH, 20。C，3.5 h. 
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1-4-4 Synthesis of (l/?,65)- and ( l i?,25,65)-cyclopheI l i to l 2 and 4 10-12 
(lR,6Sy and (li?,25,65)-cyclophellitol have also been synthesised by the 
Tatsuta g r o u p 10-12 using the same strategy as in the synthesis of cyclophellitol (via the 
nitrile oxide cycloaddition) but with a different starting material. Scheme 5 shows the 
synthesis starting from D-galactose 45. The key intermediate oxime 46 was obtained 
following the same procedure described in Scheme 2 for the synthesis of cyclophellitol 
1. Treatment of oxime 46 with sodium hypochlorite gave a mixture of isoxazolines 4 7 




Y I ^ ^ ^ ^ ) 、 NaOCi 1 
OH J h OBn 
D-galactose 45 4 6 
OH OH 
/ ^ ^ . 、 、 \ O B n 人.、、、〇Bn 
O + 0 
OBn OBn 
47 (15%) 48 (75%) 
H2, Ra-Ni H2, Ra-Ni 
AcOH AcOH 
(75%) (50 ： 49 = 2 8 % ： 70%) 
HO OH HO OH 
+ 4 9 
OBn OBn 
4 9 5 0 
Scheme 5 
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48 gave the desired keto-alcohol 49 together with the undesired 50 in the ratio of 
70 : 28. The keto-alcohol 49 underwent the same procedures as in Scheme 2 to give 
the (l/?,65)-cyclophellitol 2.10，n 
Synthesis of (l/?,25,65)-cyclophellitol 4 starts from the isoxazoline 48 
obtained from D-galactose as shown in Scheme 5. Hydrogenolysis of 48 in the 
presence of boric acid gave quantitatively the keto-diol 50 without epimerization of the 
centres adjacent to the carbonyl function. Reduction of 50 with Zn(BH4)2 in the 
presence of MgBr ! gave the triol 51 in 60% with its C - 6 epimer in 17%. 
Regioselective benzylidenation of 51 followed by mesylation afforded 52. 
Hydrogenolysis of 52 followed by base-induced epoxidation completed the synthesis 
o f4 (Scheme 6). 12 
OH HO OH HO OH 
//"•..^ .^、、、OBn . I/,,,.入、、、OBn k ^ ^ O B n 
o i l J I 一 「 
、N ^ Y ‘ " z O B n O ^ Y ' ^ O B n Hcf• 
OBn OBn OBn 
4 8 5 0 5 1 
Ph 
人 
k /^^ .、、、〇Bn 
iii- iv 「 1 V - vi 




Scheme 6 Reagents and conditions: i. H〗，Raney-Ni, B(0H)3，dioxane (100%); ii. 
Zn(BH4)2，MgBr2, THF, 0 1 h (77%, a : p = 60 : 17); i i i . PhCH(0Me)2， 
camphorsulfonic acid, DMF, 50。C，1 h; iv. MsCl, pyridine, 25。C，12 h; v. H〗， 
Pd(0H)2，MeOH (50% from iii.)； vi. NaOMe, MeOH, 0。C，3 h (60%). 
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I I Results and Discussion 
I I - 1 General Strategy 
This section describes the synthesis of cyclophellitol and its analogues. 
Comparison of the structures of the target compounds 1-4 shows that they share three 
common stereogenic centres at C-3, C-4, and C-5 (Scheme 7). Cyclophellitol 1 and 
the epoxide 2 differ from epoxides 3 and 4 in having opposite stereochemistry at the 
, 0 H / O H / O H z O H 
,3} o t f J 0)：：[ 丫 J 
丫 、 O H ^ y " 、 H Y ' ^ O H 咖 
OH OH OH OH 
1 门 2 3 4 
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C一2 hydroxy group. Compounds 1 and 2 as well as 3 and 4 differentiate from each 
other by the epoxide stereochemistry, i.e. 1 and 3 have an a-epoxide while 2 and 4 
have a P-epoxide. Retrosynthetically, 1 and 2 can be obtained from epoxidation of the 
alkene 53 with a p -OH at C - 2 and similarly, alkene 54 may be the precursor of 3 and 
4. The alkenes 53 and 54 may be obtained from the oxirane 55 via a base-induced 
elimination^^' 49，50 q j . from the cyclic sulfate 56. The epoxide moiety in 55 may be 
introduced by epoxidation of the alkene obtained from the deoxygenation of the diol 
57. The cyclic sulfate 56 can be formed from the same diol 57 using the Sharpless 
procedure.^ ^  Compound 57 is actually a protected pseudo- p-D-mannopyranose. In a 
previous synthesis of pseudo-a-D-glucopyranose 60 by Tang et alj'^ compound 59 
was formed from (-)-quinic acid 58 in 8 steps (Scheme 8). 
.OBn .OH 
HO, .COOH 广 广 
8 steps ^ A s ^ O A C ——^ 
H C / V ^ H H c / V ^ O B n H c / ^ 、 
OH OH OH 
(-)-Quinic acid 58 59 60 
Scheme 8 
The present work demonstrates further the versatility of (-)-qumic acid 58 as a 
homochiral starting material in organic synthesis. We were encouraged by the previous 
work of Tang in the enantiospecific synthesis of an antitumour agent COTC 
{2-crotonyloxymethyl-(4/?,5i?,6i?)-4,5,6-trihydroxycyclohex-2-enone},^^ pseudo-p-
D-fructopyranose，54 pseudo-p-D-mannopyranose产 pseudo-ot-D-mannopyranose，52 
and pseudo-a-D-glucopyranose 60.52 Recent syntheses employing (-)-quinic acid 58 
as starting material include 1 a,25-dihydroxy- 19-nor-vitamin antibiotic (+)-
negamycin，56 肌d the A-Ring precursor for daunomycin.57 
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The synthetic strategy is shown in Fig. 5. The sites to be modified in 58 are at 
(deoxygenation of the tertiary alcohol and reduction ofcarboxyl group), C-1 , C -
6 (introduction of an epoxide stereoselectively), C-2 (inversion of hydroxy group for 1 
and 2), and C - 4 (introduction of a hydroxy group stereoselectively). As mentioned 
above，all four target compounds share the three common stereogenic centres at C-3， 
C-4，and C-5, so our synthetic plan was to establish the hydroxy groups at C - 3 and 
C一4 and the hydroxymethyl group at C-5 first. Then we would need to address the 
stereocentre at C-2. Lastly, we would have to fabricate an epoxide moiety between C一 
1 and C -6 with the correct stereochemistry. 
Deoxygenation and reduction 
/ 
HO,, COOH 
^ ^ Introduction of hydroxy group 
Introduction of [e 
an epoxide ^ H C A I ^ O H 
OH 
58 
retention of configuration for 3 and 4 
inversion of configuration for 1 and 2 
Fig. 5 
11-2 Synthesis of the diol 57 
The synthesis of the diol 57 follows the reaction sequence developed by 
Tang52-54 with some modifications. The lactone 61 was synthesized previously using 
Gero，s procedure^^ by boiling a mixture of (-)-quinic acid 58’ cyclohexanone, Dowex 
H The numbering in cyclophellitol is used. 
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50 WX8 resin (H+)’ DMF, and benzene with azeotropic removal of water. In this 
work，we followed a simplified protocol developed by S t o o d l e y ^ ^ for its preparation by 
boiling (-)-quinic acid 58，and cyclohexanone in the presence of a catalytic amount of 
H2SO4 or H3PO4 with azeotropic removal of water (Scheme 9). Thus, the lactone 61 
was obtained in 83% yield. 
H 乂 OOH 〜 H ^ O HO COOMe 
I ‘ — I NaOMe, L 
HO、、、.S^OH [J2SO4 or 〇、、、,^^ MegH, ' 
H3PO4 cat. H = q i OH 
〇H (83%) / - V O (87%) 
(-)-quinic acid ^ ~ f 
5 8 6 1 6 2 
Scheme 9 
Reaction of the lactone 61 with sodium methoxide in methanol at 0 resulted 
in cleavage of the lactone functionality to yield the diol 62 in 87% yield together with 
8% recovery of 61 (Scheme 9). The incompleteness of this reaction is attributed to the 
equilibrium as shown in Fig. 6. The initial opening of the lactone ring gave the 
intermediate 61a in such an axial conformation which favours the reformation of 
lactone 
• I 。 -O'e 丫 。 (T (T t ^ 
6 1 61a 6 1 b 
Fig. 6 
Oxidation of 62 with concomitant elimination of the tertiary hydroxy group was 
accomplished by treatment with 4 equivalents of pyridinium chlorochromate (PCC) and 
3 equivalents of pyridine in the presence of 3 A molecular sieves. Thus the enone 64 
was obtained in 86% yield without isolation of the intermediate 63 (Scheme 10). The 
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oxidation step is completed within several hours as shown by TLC and the elimination 
of tertiary hydroxy group in 63 is a thermodynamically favourable process under the 
relatively basic conditions. 
H 乂 O O M e p c c , 「 H O c O O M e ] 尸 M e 
^ ^ ^ ^ pyridine, 
— • 一 
6 2 6 3 6 4 
Scheme 10 
Reduction of the carbonyl functionalities of the enone 64 with 
diisobutylaluminum hydride (DIBAL-H) a t - 4 0 ° C gave the diol 65 as the sole product 
in 86% yield (Scheme 11). The reduction of the ketone moiety is stereoselective in 
which the hydride attacks at the less hindered p-side since the a-side is blocked by the 
bulky cyclohexylidene protecting group. At this stage，we have to select a suitable 
protecting group before further manipulation. The silyl protecting group was not 
recommended since it had been reported that the silyl group wi l l migrate under basic 
conditions.53 So, the less expensive benzyl protecting group was chosen in our 
synthesis which could be removed at the final stage via hydrogenolysis. Accordingly, 
COOMe OH OBn 
X i. NaH, THF, I 
DIBAL-H, ^ r ^ ^ 广 、 
二 e ， B n B r , "BU4M’ ^ o、、、'V'"OBn 
(86%) P ^ O reflux 
O Q _ Q 
6 4 6 5 6 6 
Scheme 11 
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treatment of the diol 65 with NaH at 0 in THF followed by addition of benzyl 
bromide (BnBr) and a catalytic amount of "BU4NI gave compound 66 in 82% yield 
(Scheme 11). 
The carbon-carbon double bond in 66 was subjected to a regio- and stereo-
controlled hydroboration-oxidation sequence by using a BH3 / H2O2 / N a O H / T H F 
system’ furnishing exclusively the p-alcohol 67 in 83% yield. The free hydroxy group 
in 67 was protected previously as an acetate as in compound 59,^^ but in this 
synthesis, protection with the benzyl protecting group was preferred. Blocking of the 
hydroxy group in 67 with benzyl bromide gave compound 68 in 82% yield (Scheme 
12). 
< O B n / O B n ^ O B n 
Z ^ A ^ O H i. NaH, THF. 太.QBn 
「 ’ BH3.THF j \ \ 
6 6 6 7 6 8 
Scheme 12 
The ^H NMR spectrum of 68 summarised in Fig. 7 indicated clearly the 
stereochemistries at C一4 and C-5 . The coupling constants of 8.7 Hz between H3-H4 
and H4-H5 are characteristic of their diaxial orientation and supports the assignment of 
the p -OH at C -4 after the hydroboration-oxidation sequence. 
H i h H5 
3 ,H.6 H • II i l J j i H ？ i ^ H 
「BnO He] 广 
H4 He ~ - H5 8 7 Hz H4 
\ _ / 68 
Fig. 7 
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Hydrolysis of 68 using trifluoroacetic acid (TFA) in CH2CI2 gave the diol 57 
in 90% yield (Scheme 13). Thus the diol 57 was obtained from (-)-quinic acid 58 in 8 
steps with an overall yield of 27%. 
/ O B n z O B n 
CF.COOH.H.O. ^ ^ O B n 
.L J . CHpCI? 
c f V ^ O B n (90%) H c / V ^ Z Q B n 
OH 
6 8 5 7 
Scheme 13 
I I -3 Synthesis of the allylic alcohol 54 
At this stage, we have to transform the diol 57 to the allylic alcohol 54. 
According to the Sharpless protocol,51’ 61，62 the diol 57 was treated with thionyl 
chloride in the presence of triethylamine at 0 to give the cyclic sulfite 69. This cyclic 
sulfite 69 was further oxidised with catalytic RUO4 in CCI4-CH3CN-H2O at 0 °C to 
give the cyclic sulfate 70 (Scheme 14). The cyclic sulfate 70 could also be prepared in 
89% yield without isolation of the cyclic sulfite 69. The artifice of this reaction lies in 
the removal of the amine since it was reported that the amine would inactivate the 
ruthenium catalyst. 51 The ^H NMR spectrum of 70 shows 2 protons deshielded to 
^ O B n ^ O B n ^ O B n 
= ？ = 
A . j O B n SOCI2, ^ x k ^OBn Nal04, 
I EtaN, , r 丫 RuCl3 (ca t . ) . , [ [ 
Hcf . V . ' " O B n 〇、、、,k^ 、oBn Sg： c f 
OH (TC 0 = S - 0 
0 ' (89%) \ 
5 7 6 9 7 0 
Scheme 14 
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4.91 and 5.10 ppm arising from the protons attached to the cyclic sulfate moiety. The 
IR spectrum shows characteristic S=0 absorption at 1210 cm—i and in the mass 
spectrum, the M+ - C7H7 fragment was observed at mJz 419 for 70. 
The cyclic sulfate moiety has been described as an epoxide analogue and opens 
readily in a 8^2 manner by a number of nucleophiles such as the azide’ benzoate, 
acetate，hydride, fluoride, etc. 62 The high reactivity of cyclic sulfates has been 
attributed to the ring strain, even though the origin of the ring strain is not very clear. 
In addition to the ring strain, the good leaving ability of the ROSO3- moiety makes the 
five-membered cyclic sulfate very reactive towards various reagents.^^ 
Ring opening of the cyclic sulfate 70 with "BU4NI in refluxing THF gave the 
iodo alcohol 71 in 83% yield after acidic workup (Scheme 15). The regioselectivity of 
the initial attack was identified by acetylation of the hydroxy group in 71 with AC2O/ 
pyridine/CH2Cl2 to give the iodo acetate 72. The ^H NMR spectrum of 72 shows an 
apparent triplet at 5.49 ppm with coupling constants of 3.5 Hz which confirms that the 
hydroxy group in 71 is attached to C-2 and at the equatorial position. 
/ O B n ^OBn ^OBn 
丫 reflux ^ \ \ AcgO, pyridine, ^ \ \ 
O^V'- '^OBn . A J - ^ o e n . ^ ' " ^ O B n 
0 = 8 - 0 (wz。j OH (95%) OAc 
WQ 
70 7 1 7 2 
Scheme 15 
Treatment of the iodo acetate 72 with 1,8 -diazabicydo[5.4.0]undec-7-ene 
(DBU)63 in refluxing xylene gave the alkene 73 in 83% yield (Scheme 16). The ^H 
NMR spectrum of 73 shows 2 H with a ddd at 5.76 ppm and a dd at 5.93 ppm arising 
from the 6-H and 5-H respectively. The coupling constants for H5-H5 is 9.6 Hz (Fig. 
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Methanolysis of the acetate 73 furnished the allylic alcohol 54 in 4 steps from 70 and 
in an overall yield of 62% (Scheme 16). 
/ O B n OBn nsn 
f ？ 三z 
^ x ^ ^ ^ O B n DBU， A .OBn 
I xylene, ^ 「 J NaOMe (cat.),^ [ 丫 
y k ^ . v reflux L Jv,, MeOH L 广 " 
r i OBn (83。/。） Y OBn (95%) Y ' ^ O B n 
OAc OAc OH 
7 2 7 3 5 4 
Scheme 16 
It was envisaged that the ROSO3" moiety after the nucleophilic attack can only 
be hydrolysed in the presence of acid，5i’ 62’ 65 ^^ treatment of the intermediate 74 
(obtained from nucleophilic attack by the iodide) directly with DBU gave the desired 
allylic alcohol 54 in 61% yield after acidic hydrolysis (Scheme 17). 
产 「 严 1 /OBn 
r V ^ " " " B _， T H F , ^ O B n 丨ene’ ^ O B n 
reflux [ J 2. H2SO4, THF' t l 
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Scheme 17 
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It was reported that the oxirane 75 can be isomerized to the allylic alcohol 76 
by the Sharpless-Reich protocol (Scheme 18). 66 in a similar manner, our cyclic sulfate 
70 could be elaborated to the allylic alcohol 54. 
/ O B n OBn 
Jk^OBn 1PhSeNa.EtOH.THF j T 
p 丫 2. MCPBA, CH2CI2. - 4 0 X " 
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Scheme 18 
Thus, treatment of the cyclic sulfate 70 with the phenylselenide anion in THF 
followed by acid hydrolysis formed the seleno-alcohol 77 as a sole product in 80% 
yield. The seleno-alcohol 77 was then subjected to an oxidative-elimination procedure 
to give the allylic alcohol 54. The selenoxide produced from the oxidation of 77 with 
m^r^-chloroperbenzoic acid (MCPBA) at - 70 was treated with Hiinig's base to give 
the allylic alcohol 54 in 58% overall yield (Scheme 19). The phenomenon that the syn-
elimination occurs away from the hydroxy group appears to be general. 6? The 
regioselectivity of the initial attack by the selenide anion was confirmed by the allylic 
alcohol 54 obtained. 
^OBn ^OBn ^OBn 
睡 OT 
J ^ JDBn 1 • PhSeNa. EtOH, J . .OBn 1. MCPBA, C H 2 C I 2 , 人 OBn 
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Scheme 19 
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Thus，we have shown three ways of transforming the cyclic sulfate 70 into the 
allylic alcohol 54. Among the three methods, the second method, i.e., the in situ 
elimination of the iodide 74’ is the most satisfactory both in terms of the yield and of 
the number of steps. Remarkably, the ring opening of the cyclic sulfate 70 by the 
iodide or by the selenide is regioselective. This fact can be rationalized base on the 
effect of neighbouring polar substituents on the development of the 8^2 transition 
state. As shown in Fig. 9，the transition state 70a arising from nucleophilic attack at 
C-1 wi l l exert a dipole which is aligned with the existing dipole at C-2, the energy of 
the transition state is correspondingly increased.68 Nucleophilic attack at C -2 wil l 
evoke 2 such dipole-dipole interactions, which is influenced by 2 dipoles at C - 1 and 
C—3，resulting in an even less favourable transition state 70b. 
Mil- NuC 〇Bn "^u oBn 、、、 
I ^ \严 
\\ ^ s = 0 \ o — s ^ o 
、?" 、 - / / o 
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Fig. 9 
I I - 4 Synthesis of Cyclophellitol 1 and the (IR,65)-diastereoisonier 2 
The hydroxy group in the allylic alcohol 54 is of opposite stereochemistry to 
the C-2 hydroxy group in cyclophellitol 1，so our next objective was to invert the 
hydroxy group in 54 by the Mitsunobu reaction. 69 Treatment of the allylic alcohol 5 4 
with benzoic acid, triphenyl phosphine (PPh�）and iisopropyl azodicarboxylate 
(DIAD) in toluene at 0 gave the p-benzoate 78 in 93% yield (Scheme 20). The ^H 
NMR spectrum of 78 shows the olefinic protons at 5.66 and 5.77 ppm respectively. 
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As shown in Fig. 10，the coupling constant of 8.0 Hz between H^ and H2 is 
characteristic of the pseudo-axial orientation at C-1 and supports the assignment of the 
p-benzoate after the Mitsiinobu inversion (compare with the a-acetate 73，the coupling 
constant of H「H2 is 3.2 Hz). The dihedral angle H1-C1-C2-H2 calculated from the 
Karplus's equations^ is about 159 
H2 
2 Hz 9.8 Hz 
H H5 H4 H3 
10 HZ 入 _ z 
I Hi / 2Hz \ 8.0 Hz 
He Hi H2 
H3 7 8 
Fig. 10 
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Epoxidation of the double bond in 78 with MCPBA in CH2CI2 gave an 
inseparable mixture of diastereoisomeric oxiranes 79a and 79b in 66% combined yield 
(Scheme 20). The ^H NMR spectrum shows 2 isomers in the ratio of 30:70. 
Debenzoylation of the inseparable oxiranes 79a and 79b with K2CO3 in MeOH gave 2 
epoxy alcohols 80 and 81 in 95% isolated yield with a ratio of 27:73 respectively 
(Scheme 20). The assignment of the stereochemistry of the oxiranes 80 and 81 is 
made by comparison with the major oxirane 81 formed from the allylic alcohol 53 
(Scheme 21). Methanolysis of the p-benzoate 78 afforded the allylic alcohol 53 in 
94% yield which underwent hydroxy-directed MCPBA epoxidation to give 80 and 81 
in 70% yield with a ratio of 6:94 respectively. The major oxirane 81 obtained from the 
hydroxy-directed MCPBA epoxidation should give a p-epoxide.?。 
/ O B n z〇Bn 
^ x k ^ O B n ‘OBn 
r r NaOMe (cat.), MCPBA. 
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Scheme 21 
In order to reverse the stereoselectivity of epoxidation, the hydroxy group in 53 
is blocked with the bulky r^rr-butyldimethyl silyl (TBDMS) group. Treatment of the 
allylic alcohol 53 with TBDMSCl, imidazole, DMAP in DMF gave the silyl ether 82 in 
91% yield. MCPBA epoxidation of 82 gave 2 diastereoisomeric oxiranes 83 and 84 
in 72% isolated yield with a ratio of 61:39 favouring the a-oxirane. The assignment of 
the stereochemistry of the oxiranes is made simply by desilylation of 83 and 84 
separately with ”BU4NF，affording 80 and 81 respectively in 94% yield (Scheme 22). 
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Scheme 22 
Finally, hydrogenolysis of the anti-Qipoxy alcohol 80 with a catalytic amount of 
5% palladium-on-charcoal in EtOH gave cyclophellitol 1 in 93% yield (Scheme 23). 
The melting point and optical rotation of synthetic 1 were in accord to those reported by 
the Umezawa group: 1 m.p. 146—148。C; [afe^^ + IQO (C 0.3’ H2O) {lit.，！ m.p. 
149—151。C; [a]D27 + 103 (c 0.5, H2O)}. Acetylation of cyclophellitol 1 with 
Ac20/pyridine/DMAP gave its tetra-acetate 85 in 91% yield (Scheme 23). The ^H and 
13c NMR data were identical to those reported by the Vogel group^ for racemic 85， 
m.p. 105—106。C; [a]D23 + 100 (c 0.2, CHCI3) (lit”9 oil). 
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Scheme 23 ‘ 
Similarly, hydrogenolysis of the ^«-epoxy alcohol 81 with a catalytic amount 
of 5% palladium-on-charcoal in EtOH gave the (l/?,65)-diastereoisomer 2 i n 
quantitative yield (Scheme 24). The melting point and optical rotation of synthetic 2 
were in good agreement to those reported by the Umezawa group: n m.p. 155一157 
。C; [a]D23 + 83.3 (c 0.3’ H2O) {lit.,6，^ m.p. 150—152。C; [a]^^^ + 80 (c 0.4, 
H2O)}. Acetylation of 2 with Ac20/pyridine/DMAP gave its tetra-acetate 86 in 83% 
yield (Scheme 24), oil; [aJo^^ + 90.4 {c 0.7，CHCI3). 
/ O B n ^OH ^OAc 
三 — -
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Scheme 24 
In conclusion, cyclophellitol 1 and its (li?,65)-diastereoisomer 2 could be 
synthesized from (-)-quinic acid 58 in 17 steps with 4.5% overall yield and in 15 steps 
with 8.6% overall yield respectively. 
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I I - 5 Synthesis of the (23)- and (LR,25,65)-diastereoisoiners 3 and 4 
The aUyl acetate 73 was used for the synthesis of the (2S)- and (1/?,25,65)-
diastereoisomers 3 and 4. MCPBA epoxidation of the allyl acetate 73 in boiling 
CH2CI2 gave 2 oxiranes 87 and 88 in 77% yield with a respective ratio of 45 ： 55 
(Scheme 25). Methanolysis of the epoxy acetates 87 and 88 separately gave the 
y〇Bn z〇Bn ^OBn 
f f V B n ~ O B n ^ O B n 
i OBn (770/0) V ^ , O B n ^ V ^ Z Q B n : : : 
OAc OAc OAc 
8 7 8 8 
87 : 88 = 45 : 55 
K2CO3 (cat.), K2CO3 (cat.), 
MeOH MeOH 
(94%) (91%) 
z 〇 B n z O B n 
= 一 
< r T ocT J 
OH OH 
8 9 9 0 
Scheme 25 
corresponding epoxy alcohols 89 and 90 in 94% and 91% yield respectively (Scheme 
25). The assignment of the stereochemistry of the oxiranes 87 and 88 was established 
as described previously. Hydroxy-directed MCPBA epoxidation?�of the allylic 
alcohol 54 gave solely the ^^n-epoxy alcohol 89 in 95% yield (Scheme 26). 
^OBn ^OBn 
^OBn jOBn 
丫 MCPBA，^ 〇、、、< 丫 
V ^ O B n " • y - . O B n 
OH OH 
5 4 8 9 
Scheme 26 
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Using the same strategy as above, blocking of the hydroxy group in 54 with 
TBDMSCl gave the silyl ether 91 in 96% yield MCPBA epoxidation of the silyl ether 
91 gave 2 diastereoisomeric oxiranes 92 and 93 in 67% isolated yield with a respective 
ratio of 24:76 (Scheme 27). Their stereochemistries were assigned based upon 
desilylation and comparison with compounds 89 and 90. Thus the oxirane 89 and 90 
could be obtained from the allylic alcohol 54 in 3 steps with 14% and 46% overall yield 
respectively. 
/ O B n zOBn 
I TBDMSCl. imidazole. ^ 广 丫 
k ^ ^ O R n DMAP (cat.), DMF. r.t. 
i 〇Bn (96。/。） Y 力已 n 
OH TBDMSO 
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一 一 
？ = 
o t f J + ocT T 
= I 
TBDMSO TBDMSO 
92 93 92 :93 = 2 4 : 7 6 
"BU4NF, THF ''BU4NF. THF 
(92%) (94%) 
8 9 9 0 
Scheme 27 
Finally, hydrogenolysis of the ^n-epoxy alcohol 89 with a catalytic amount of 
5% palladium-on-charcoal in EtOH gave the (25>diastereoisomer 3 in 91% yield for 
the first time (Scheme 28), m.p. 148—150。C; [alo^"^ + 7.0 (c 0.4, H2O). 
Acetylation of 3 with Ac20/pyridine/DMAP gave its tetra-acetate 94 in 91% yield 
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(Scheme 28), m.p. 111.5—113 Md〗〕一 55.3 (c 0.4，CHCI3). 
_/〇Bn / O H OAc 
？ = = 
O r ' r ^ O B n H2.5% Pd/C. 。、、、、'.f"^ 〇H AC2O, pyridine. 
U 、 。 R n Et〇H ' " . . k ^ D M A P M . ) • 〇 " ' , . \ 7 , 
i 〇Bn (91%) T OH (91。/。）\ V ^ 々 A c 
OH OH 5AC 
8 9 3 9 4 
Scheme 28 
Similarly, hydrogenolysis of the a^zri-epoxy alcohol 90 with a catalytic amount 
of 5% palladium-on-charcoal in EtOH gave the (1凡25"，65>diastereoisomer 4 in 89% 
yield (Scheme 29). The melting point and optical rotation of synthetic 4 are compared 
with those obtained from the Umezawa group 4，m.p. 129~131 °C; [a ]D” 一 3 9 . 5 
(c 0.9’ H2O) {lit.，i2 oil; [a]D25 —76 (c 0.1, H^O)}. Acetylation of 4 with Ac^O 
/pyridine/DMAP gave the new tetra-acetate 95 in 93% yield (Scheme 29)，m.p. 74—75 
。C; [aJo^^ 0 (c 0.4，CHCI3). 
/ O B n ^ O H ^OAc 
= 一 
• 一 — 
I H2，5%Pd/C’ I A C 2 O，p y r i d i n e . .门Z 丫 
^ ^ 人 EtOH 。 义 丄 DMAP (cat.) 。 义 J, , 
^OBn (890/0) Y ^ '^ OH (93%) 
OH OH OAc 
9 0 4 9 5 
Scheme 29 
In conclusion, the (25)- and (15,25,6/?)-diastereoisomers 3 and 4 could be 
synthesized from (-)-quinic acid 58 in 13 steps with 12.6% overall yield and in 15 
steps with 6.0% overall yield respectively. Remarkably, the diastereoisomers 2 and 3 
could also be obtained stereoselectively by hydroxy-directed MCPBA epoxidation of 
the allylic alcohols 53 and 54 respectively. 
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I I - 6 Comments on the MCPBA Epoxidation 
In 1957, Henbest and Wilson?。reported their work on the epoxidation of 
cyclohexene derivatives possessing various allylic substituents. They observed that 
cyclohexenes having a free hydroxy group in the allylic position 97 exhibited strong 
preference for epoxidation syn to the functional group. The corresponding acetate 98， 
however, reacted at slower rates than the free alcohols and did not undergo preferential 
^y^ attack. For the silyl ether 99，the stereoselectivity is even reversed” These 
observations were reasonably explained in terms of a transition state 96 involving 
hydrogen bonding between the unsaturated alcohol and the peroxyacid (Fig. 11). Such 
bonding determines the stereoselectivity of the reaction based on the geometry of the 
transition state and can account for the rate increase by an intramolecular acid catalysis. 
R 
\ c = o 
I： ... 
H O... ...-H / "O 
丄 ...... 




In 1970，Whitham^^ further examined the kinetics and stereochemistry of the 
epoxidation of the epimeric 5-r-butylcyclohex-2-enols, which disclosed the significance 
of the pseudo-axial and pseudo-equatorial nature of the allylic hydroxy group on the 
steric course of epoxidation. Due to the bulky r-butyl group in 100-103，the 
conformation of these compounds are presumably fixed and the hydroxy groups in 
100 and 101 lie in a pseudo-axial position while in 102 and 103, the hydroxy groups 
are in a pseudo-equatorial position. The data in Table 2 shows that the pseudo-
equatorial allylic hydroxy group in 102 induces a higher degree of stereoselectivity 
more than the pseudo-axial one 100. Again no syn selectivity is observed in the 
epoxidation of the acetates 101 and 103，and the course can be explained on simple 
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Table 2 Epoxidations of cyclohexene derivatives with allylic hydroxy substituents. 
Compounds Entry % yields^ syn/anti Ref 
f ^ 9 7 : X = H 86 91 : 70,72 
9 8 : X = Ac 68 43:57b 70，72 
T 9 9 : X = TMS 89 10:90。 71 
OX 
^ ^ ^ ^ ^ 泊 u 
I 1 1 0 0 : X = H 90 84:16b 72 
101 : X = Ac _ 32:68b 72 
I J 102 : X = H 88 96:4b 72 
103 : X = Ac _ 5 5 : 4 5 b 72 
OX(e) 
^OBn 
X .OBn 54 : X 二 H 95 100 : 』 this work 
(I J 73 : X = Ac 77 45 :55^ this work 
l i ^ ” " O B n 9 1 : X = TBDMS 67 24 :76^ this work 
5 x ( a ) 
z〇Bn 
J . ^OBn 53 : X = H 70 9 6 : t h i s work 
7 8 : X = Bzl 66 70:30^ this work 
82 : X = TBDMS 72 39:61^ this work 
OX⑷ 
a. yields refer to the isolated yields; b. the syn/anti ratio is determined by glc; c. the ratio is 
determined by ^H NMR; d. isolated ratios. 
steric terms: when the acetoxy group is axial 101，it directs epoxidation anti to itself; 
when equatorial i t does not exert any influence. Whitham^^ proposed that the 
preferred geometry of the allylic alcohol at the transition state for epoxidation is close to 
that dipicted in Fig. 12. In the case of pseudo-equatorial cyclohexenol the partial 
conformation about C - 1 and C一2 already resembles the preferred geometry ( r2 = H, 
R1 = ~ C H 2 ~ o f ring). For a pseudo-axial cyclohexenol, however, with a smaller 
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C=C-C-0 , the most stable hydrogen bonded transition state cannot be formed 
C-2 
\ C -1 
R2 
Fig. 12 
Since we have not perform any kinetic study on the rate of epoxidations, so 
only substitution effects on the pseudo-axial and pseudo-equatorial hydroxy groups 
could be compared. Our results show that the pseudo-axial hydroxy group in 54 
directs the epoxidation better than the pseudo-equatorial hydroxy group in 53，which 
opposed the results of Whitham. In order to solve this problem, conformational studies 
should be carried out and comparison with the preferred geometry proposed by 
Whitham should be made. When the hydroxy group is blocked as its ester or silyl 
ether, the syn selectivity is reversed gradually with the bulkiness of the blocking group. 
1 1 H2 H2 /[ \ 
H4 I H4 r / \ \ 
H 3 介 / O X 〜 H 3介 
f 已 u 
54 : X = H 53 : X = H 
73 ： X = Ac 78 : X = Bzl 
91 : X = TBDMS 82 : X = TBDMS 
Fig. 13 39 
This can be visualised in terms of the cone angle as shown in Fig. 13，the bulkier the 
blocking group, the higher the anti selectivity. The blocked hydroxy compounds in the 
pseudo-axial position 91 and 73 play a better role in blocking the attack than its 
pseudo-equatorial counterparts 82 and 78. This can be depicted in Fig. 13，the 
pseudo-axial protecting groups block the attack of the peroxyacid more efficiently than 
the pseudo-equatorial ones. 
Interestingly, the benzoate 78 gave a high syn selectivity despite its bulky 
nature and the acetate 73，although occupying the pseudo-axial position, did not give 
very good anti selectivity. There may be some kind of directing effect between the 
carbonyl groups in 78 and 73, and the peroxyacid. There seems to be two factors 
operating in the MCPBA epoxidation, namely the steric effect and the electronic effect. 
In order to solve this problem, the selectivity of the less-sterically hindered formyl 
group should be investigated to identify i f there is any directing effect between the 
carbonyl group and the peroxyacid. 
I I - 7 Synthesis of the Epoxy Analogues of Cyclophellitol 104 and 105 
Our next objective is to synthesize some epoxy analogues of cyclophellitol 1. It 
was known that the epoxide ring of the conduritol epoxides is opened by the 
glycosidases regiospecifically at C -1 (Section 1-3-5)，so it is worthwhile to 
synthesize compounds 104 and 105 which also has the oxirane attached to C - 1 but 
with one chiral centre less (Fig. 14). Structurally, compounds 104 and 105 have the 
oxirane attached between C-1 and C - 2 instead of C - 1 and C - 6 in cyclophellitol 1. 
HO—y H0--4 
\ H O i ' . ( \ 
HO HO 




Interestingly, compounds 104 and 105 lack the C-2 hydroxy group which defines 
these compounds as being a glucosidase or a mannosidase inhibitor. 
Compound 104 can be easily obtained stereoselectively from the iodo alcohol 
71. Treatment of 71 with NaOMe/MeOH gave the oxirane 106 which upon 
hydrogenolysis afforded the epoxy analogue 104 in 76% overall yield for the first time 
(Scheme 30), m.p. 125,5—127。C (MeOH); [a^^^ q 0.5, H2O). Acetylation of 
104 with Ac20/pyridine/DMAP gave its triacetate 107 in 7 5 % yield (Scheme 30)，oil; 
[ a ] D ^ - 9.6 (c 0.7，CDCI3). 
/ O B n / O B n OH 
？ = = 
f 丫 NaOMe, L Hg, 5% Pd/C. ^ r ^ ^ V ^ 
人 丄 MeOH L … EtOH 
I ^ V ^ z o B n (95。/。） (80。/。） 
6 H • o 
7 1 1 0 6 1 0 4 
Z〇Ac 
I • AC2O, pyridine， 
DMAP (cat.) 
g � � � � . OAC (750/0) 
1 0 7 
Scheme 30 
The diol 57 was subjected to a Corey-Winter deoxygenation^^ Treatment of 
57 with 1,1 -thiocarbonyIdiimidazole in boiling toluene gave a thionocarbonate 108 
which was then converted into the alkene 109 by boiling with trimethylphosphite 
(Scheme 31). Thus, the alkene 109 can be obtained in 70% overall yield from 57. 
^OBn ^OBn ^OBn 
M B « 
^ X s ^ O B n 1,1'-thiocarbonyldi- ^ - ^ s ^ O B n ^ A s ^ O B n 
I imidazole, ^ | | P(0Me)3’ _ | | 
HO、、、. V ^ O B n —ene，reflux^^^、巳。丨，；工 W 、 O B n 
OH ° 
s 
5 7 1 0 8 1 0 9 
Scheme 31 
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MCPBA epoxidation of the alkene 109 gave 2 diastereoisomeric oxiranes 106 
and 110 in 85% yield with a ratio of 1:4 in which the minor product was identical to 
the oxirane 106 obtained from 71 (Scheme 32)7^ The a/zft^oxirane 110 is expected to 
be the major product based on steric consideration. Finally, hydrogenolysis of oxirane 
110 gave the epoxy analogue 105 in 92% yield for the first time (Scheme 32)，oil; 
[a]D26 + 37.1 (c 0.6, H2O). Acetylation of 105 with Ac20/pyridine/DMAP gave its 
triacetate 111 in 81% yield (Scheme 32)，m.p. 59—61 [aj^^^ + 41.7 (c 0.5, 
CDCI3). 
/OBn zOBn ^OBn 
？ = = 
MCPBA, L 1 \ ^ \ \ 
1 0 9 1 0 6 1 1 0 
. . . . . . 1 . H2.5% Pd/C, 
106 : 110 = 1 : 4 EtOH 
(92%) 
z〇Ac ^OH 
A ^ O A c «^As>〇H 
F ^ ACPO. pyridine. 「 T ^ 
、 L DMAP (cat.) \ J v . 
^ ^ " 〇 A C (81%, P > ^ " 〇 H 
1 1 1 1 0 5 
Scheme 32 
In conclusion, the epoxy analogues 104 and 105 can be prepared 
stereoselectively and enantiospecifically from (-)-quinic acid 58 in 12 steps with 15% 
and 12% overall yield respectively. 
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I I - 8 Results of biological assays 
The target compounds 1-4，104 and 105 were screened against the following 
commercially available glycosidases according to the method used by Umezawa:^ 
A. a-glucosidase (EC 3.2.1.20, from brewers yeast) 
B. p-glucosidase (EC 3.2.1.21，from almonds) 
C. a-galactosidase (EC 3.2.1.22，from Escherichia coli) 
D. p-galactosidase (EC 3.2.1.23, from Aspergillus oryzae) 
E. a-mannosidase (EC 3.2.1.24，from jack beans) 
F. p-mannosidase (EC 3.2.1.25, from snail acetone powder) 
Preliminary results are summarised in Table 3. For those compounds which show 
strong inhibition of the glycosidases within 100 M-g/ml, the IC50S are further elaborated. 
Cyclophellitol 1，the {IR,6S)- and the (1R,25,65)-diastereoisomers 2 and 4 show 
strong and specific inh ib i t ion against p-D-glucosidase, a-D-glucosidase and a-D-
mannosidase respectively. These results confirm our initial expectations (Section I -
1). Surprisingly, the (25)-diastereoisomer 3 did not show any inhibition against the p-
D-mannosidase, this may be attributed to the source of enzyme used. It was found that 
the only commercially available source of p-D-mannosidase is the snail acetone powder, 
enzyme D-glucosidase D-galactosidase D-mannosidase 
compounds a- p- a- p- a- p_ 
cyclophellitol 1 々 
(1 A?,6S)-diastereoisomer 2 V 
(2S)-diastereoisonner 3 
(1 R,2S,6S)-diastereoisomer 4 V 
epoxy analogue 1 0 4 V 
epoxy analogue 1 0 5 
Table 3 Preliminary results of biological assays of target compounds. 
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but literature survey reveals that the common sources of this enzyme are from the 
Aspergillus wentif\ and from the isoenzyme A and B of the goat liver.?6 Epoxy 
analogue 104’ which possess a p-epoxide, shows weak inhib i t ion against the p-D-
glucosidase whereas epoxy analogue 105 exhibits no inhibition at a concentration of 
160 |ig/ml. Table 4 shows a comparison of the IC50S obtained by us with those by the 
Umezawa group (Table 4).i，2，10-12 
IC50 (jig/ml), enzyme (source) 
Inhibitors 
This work Umezawa group 
HO 飞 ‘“ 




22 a-D-glucosidase ^ Vo-glucosidase 
HO^^OH (brewers yeast) (baker's yeast) 
2 
H 
HO"•< 1 1 a-D-mannosidase a-D-mannosidase 
HO^^OH Oack bean) (jack bean) 
4 
H 






1 1 2 
Table 4 Comparison of the IC50S of the target compounds. 
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The IC50S of cyclophellitol 1 and its diastereoisomers 2 and 4 are of the same 
order of magnitude as those reported by the Umezawa group. 1’ 2’ 10-12 The slight 
differences between these results may be attributed to the different sources of enzymes, 
and the concentration of enzymes and substrates used in the biological assays. 
With respect to the stereochemistry of the epoxide moiety, epoxides 1，and 104 
which possess p-epoxides, are p-glycosidase inhibitors whereas compounds 2，and 4 
which possess a-epoxides, are a-glycosidase inhibitors. Thus, the inhibitors are 
specific with respect to the epoxide stereochemistry. 
Comparison between epoxides 1，2，and 4 clearly shows that cyclophellitol 1 is 
the most potent inhibitor. This may be attributed to the regiospecificity in the opening 
of the oxiranes by the enzymes. For the conduritol epoxides, the epoxide rings are 
regiospecifically opened at C -1 (Scheme 1). So we envisaged that for cyclophellitol 1 ’ 
the epoxide ring is also opened by the p-D-glucosidase regiospecifically at C -1 , i.e., 
diaxial opening of the epoxide ring. But for epoxides 2 and 4，opening at C - 1 is 
energetically unfavourable, leading to diequatorial opening of the epoxide ring. The 
above postulate could be proved by doing biological assays followed by identification 
of the ring opened products. 
Comparison between epoxides 1 and 104 reveals that the position of the 
epoxide ring is extremely important. Although the p-D-glucosidase can also be 
inhibited by the epoxy analogue 104，the activity is enormously decreased by a factor 
of 100. This may be attributed to the fact that the initial protonation of the epoxide ring 
is not at close proximity to the amino acid. Another possible reason for this 
observation is the significance of the C - 2 hydroxy group in the recognition of the 
specific enzyme. This factor combined with the preference for diaxial epoxide opening 
may result in lost of inhibition for the epoxy analogue 105 against the a-glycosidases. 
The aziridine analogue of cyclophellitol 112 is a better inhibitor of p-D-
glucosidase than cyclophellitol l } ^ This may be attributed to the higher reactivity of 
the aziridine ring compared with that of the epoxide ring. Since the aziridine is more 
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basic than the epoxide so the initial protonation is much favourable. 
The C-2 and C-4 hydroxy groups are vital for the recognition of the specific 
enzymes. The a-OH at C-2 defines epoxides 1 and 2 as glucosidase inhibitors while 
the p -OH defines epoxide 4 as a mannosidase inhibitor. The above compounds all 
possess an a -OH at C-4 are inactive against both a - and p-galactosidases. 
The significance of the C-5 hydroxymethyl group had been reported by 
Withers4i’ 77 employing kinetic studies of cyclophellitol 1，conduritol B epoxide, and 
conduritol aziridine (1,2-dideoxy- l,2-epimino-mj<9-inositol). The presence of the C-5 
hydroxymethyl substituent has introduced an absolute specificity as far as enzyme 
inhibition is concerned. 
Based on molecular modeling, Winklei^^ suggested that potent inhibitors of a— 
mannosidase may be good topographical analogues of the mannopyranosyl cation. 7 8 
Also, Huber79 suggested that the strong inhibition of E. coli p-galactosidase by L-
ribose may be due to the potential geometrical similarity of the p-furanose form 113 of 
the sugar to the oxocarbonium ion-like transition state for galactoside hydrolysis. From 
the above facts, it leads us to speculate that the potent inhibition of the above epoxides 
may partly due to the conformation of the cyclohexane ring resembling the glyco-
pyranosyl oxocarbonium ion (Fig. 15). 
O H O H 
CH2OH 
H 。 ^ ^ 。 ， c f H O \ C A O H 
CH2OH 
D-galactopyranosyl oxocarbonium ion p-L-ribofuranose 113 
CH2OH CHGOH O 
h 。 H £ ^ � , . H � h 豹 
D-glucopyranosyl oxocarbonium ion cyclophellitol 1 
Fig. 15 
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Although cyclophellitol 1 has been identified as an irreversible competitive 
inhibitor (suicide substrate), the other inhibitors 2, 4, and 104 are still undetermined, 
so kinetic studies in this field are recommended. Also, the syntheses of the aziridine 
analogues of 2，3，and 4 wi l l also be recommended. 
In conclusion, the epoxide ring should be regiospecifically attached between C -
1 and C-6, and the stereochemistry of the epoxide ring define these compounds as a-
or p-glycosidase inhibitors. The C-2 and C-4 hydroxy groups are expected to be vital 
in enzyme recognition. The aziridine analogues should be better inhibitors than its 
epoxide analogues. 
47 
i n Conc lus ion 
The present approach to cyclophellitol 1 starting from commercial available (-)-
quinic acid 58 is flexible, thus providing opportunities for the facile syntheses of other 
diastereoisomers 2, 3, and 4 as well as its epoxy analogues 104 and 105. The key 
intermediate, the diol 57, is available in 8 steps from the starting material using a 
modified procedure developed earlier by Tang.52-54 xhis diol 57 is transformed via the 
Corey-Winter deoxygenation into the alkene 109 which upon epoxidation furnished the 
epoxide 110 with good stereoselectivity. Thus the epoxy analogue 105 can be 
obtained in 12 steps and 12% overall yield from (-)-quinic acid. The diol 57 is 
efficiently converted into the cyclic sulfate 70 via the Sharpless protocol in 89% yield. 
The a-allyl ic alcohol 54 is obtained from the cyclic sulfate 70 via regiospecific 
substitution-elimination reactions in 61% yield. Mitsunobu reaction of 54 followed by 
methanolysis furnished the p-allylic alcohol 53 in 2 steps with 87% yield. Hydroxy-
directed MCPBA epoxidation of the allylic alcohols 53 and 54 afforded the ^^i-epoxy 
alcohols 81 and 89 respectively with excellent stereoselectivity. Steric-controlled 
MCPBA epoxidation of the silyl ethers 82 and 91 gave the anti-cpoxy alcohols 80 and 
90 with moderate or low stereoselectivity. The syntheses of 1-4 proceeded in 13-17 
steps from (-)-quinic acid and 4.5-12.6% overall yield. The epoxy analogue 104 can 
also be obtained stereoselectively in 12 steps from (-)-qumic acid and 15% overall yield 
(Scheme 33). Structure-function studies of the above 6 compounds reveal the 
importance of the stereochemistry of the epoxide ring in the differentiation of a- and p-
glycosidases. The deviation of the epoxide ring from the C - 1 and C - 6 position to the 
C - 1 and C - 2 position resulted in lost of activity or a 100-fold decrease in the IC50. 
Moreover, the C - 2 and C - 4 hydroxy groups should be necessary in enzyme 
recognition. The aziridine analogues are expected to display more potent inhibitory 
effects than their epoxy counterparts. 
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I V Experimental 
Melting points were measured on a Reichert Microscope apparatus and are 
uncorrected. Broker W M 250 spectrometer was used to obtain ^H (250 MHz), and ^^C 
(62.9 MHz) NMR spectra. Al l spectra were measured on solutions of the compound in 
deuteriochloroform with Me4Si (TMS) as internal standard unless otherwise stated. 
Chemical shifts are reported as parts per million (ppm) in 5 scale downfield from TMS. 
Coupling constants (J) are reported in hertz (Hz). IR spectra were recorded on a 
Nicolet 205 FT-IR spectrometer. EI and CI(isobutane)-mass spectra were recorded on 
a VG 7070F mass spectrometer. Optical rotations were measured on a Jasco DIP-370 
digital polarimeter using chloroform as solvent unless otherwise stated; [a]D values are 
recorded in 10'^ deg cm^ g"^ Elemental analyses were carried out at either Shanghai 
Institute of Organic Chemistry, Academic Sinica，China or MEDAC Ltd., Department 
of Chemistry, Brunei University, Uxbridge, Middlesex UBS 3PM, United Kingdom. 
Al l reactions were monitored by thin layer chromatography (TLC) performed on Merck 
precoated silica gel 6OF254 plates, and compounds were visualised with a spray of 5% 
w/v dodecamolybdophosphoric acid in ethanol and subsequent heating. Flash 
chromatography^^ was carried out on columns of Merck Keisel gel 60 (230-400 mesh). 
A l l solvents were reagent grade. Pyridine was distilled from barium oxide and stored 
in the presence of potassium hydroxide pellets. THF was freshly distilled from 
Na/benzophenone ketyl under nitrogen. CH2CI2 was distilled from P2O5 and stored 
over 4 A molecular sieves. DMF was distilled over CaH? under reduced pressure and 
stored over 3 入 molecular sieves under nitrogen. 
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Cyclophellitol 1 . ~ T o a suspension of palladium-on-charcoal (60 mg, 5% w/w) in 
absolute EtOH (1.5 cm^) under H2 at atmospheric pressure was added a solution of the 
compound 80 (189.3 mg, 0.424 mmol) in absolute EtOH (8 cm^). The suspension 
was stirred for 2 h at room temperature and filtered through a pad of Celite. The 
residue was washed with methanol (30 cm^). Concentration of the filtrate followed by 
flash chromatography [chloroform—methanol (3:1 v/v)] gave cyclophellitol 1 (69.4 mg, 
93%) as colourless needles, m.p. 146~148。C (MeOH), [ ] i t j 149—151。C (H2O)]; 
Rf 0.32 [chloroform-methanol (3:1 v/v)] (Found C, 47.7; H, 6.9. C7H12O5 requires 
C，47.7; H , 6.9); [ a ] + 100 (c 0.3, H2O) , { l i t ” l [ a b : ? ^ 103 (c 0.5, H 2 O ) } ; 
Vmax(KBr)/cm-l 3400，3490 (OH); 5H (D2O, D O H = 4.80) 2.10 ( I H , m, 5-H) , 3 .18 -
3.26 (2H, m, 1-H, 4-H), 3.35 ( IH, dd, J 8.4 and 10.0，3-H), 3.54 ( IH, br d, / 3.6， 
6-H), 3.75—3.83 (2H, m, 2-H, 8-H), 3.98 ( IH, dd, J 3.8 and 11.3，8’-H); 5c (D2O, 
dioxane was used as an internal reference, 5 67.4) 44.3, 56.8，56.9, 61.4’ 67.8，71.7， 
77.1; m/z (CI) 177 (MH+). 
(lR，2R’3S’4R，5R，6S)-5-;2:y^^?x;ym《r/27/-7-c);caZ?/cK/44.1.0]/2^ia^i^-2，3，4-fri^?/ 
2.~~To a suspension of palladium-on-charcoal (20 mg, 5% w/w) in absolute EtOH (1 
cm^) under H〗at atmospheric pressure was added a solution of the compound 8 1 
(235.5 mg, 0.528 mmol) in absolute EtOH (12 cm^). The suspension was stirred for 
30 h at room temperature and filtered through a pad of Celite. The residue was washed 
wi th methanol (25 cm^). Concentration of the filtrate followed by flash 
chromatography [chloroform-methanol (2:1 v/v)] gave the (IR,6S)-diastereoisomer 2 
(92.6 mg, 99.6%) as colourless needles, m.p. 155—157。C (MeOH), [lit.，6, ^ 
150—152。C (MeOH)]; Rf 0.32 [chloroform-methanol (2:1 v/v)] (Found C, 47.5; H, 
6.9. C7H12O5 requires C, 47.7; H, 6.9); [aJo^^ + 83.3 (c 0,3, H2O), { l i t ”6 ’ ^ 
[(X]D25 + 80 (c 0.4，H2O)}; Vmax(KBr)/cm-l 3244, 3322 (OH); 5H (D2O) 2.04 ( IH, 
m, 5-H), 3.30-3.47 (4H, m), 3.78 ( IH, dd, J 5.9 and 11.3，8-H), 3.89-3.95 (2H, 
m); 5c (D2O) 45.0，55.8, 58.2, 61.3，70.4，72.1, 74.0 ； m/z (CI) 177 (MH+). 
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(lS’2S，3S，4R，5R，6R)-5-/z;>Y/r^>jo^;72ef/i:y/-7-6mzZ?fQ^d£?[4.LO]/i£pf^me-2，3，4-rnb/ 
3.—To a suspension of palladium-on-charcoal (60 mg, 5% w/w) in absolute EtOH (2 
cm ) under H〗at atmospheric pressure was added a solution of the compound 89 
(255.9 mg, 0.574 mmol) in absolute EtOH (12 cm^). The suspension was stirred for 
3.5 h at room temperature and filtered through a pad of Celite. The residue was 
washed with methanol (30 cm^). Concentration of the filtrate followed by flash 
chromatography [chloroform-methanol (2.5:1 v/v)] gave the (2S)-diastereoisomer 3 
(92.1 mg, 91.2%) as colourless needles, m.p. 148—150 (MeOH); 
[chloroform—methanol (2.5:1 v/v)] (Found C, 47.6; H, 6.9. C7H12O5 requires C, 
47.7; H, 6.9); [oc]d24 + 7.0 (c 0.4，H2O); 3440, 3470 (OH); % 
(D2O) 2.11 ( IH , m, 5-H), 3.42-3.58 (4H，m), 3.84 ( IH, dd, J 8.0 and 11.0，8-H), 
4.00 ( IH , dd，J 4.2 and 11.0，8’-H)，4.38 ( IH, t, /4 .5 ) ; 5c(D20) 44.8, 54.4, 56.9, 
61.8’ 66.4, 66.7，73.2 ； m/z (CI) 177 (MH+). 
(lR，2S，3S，4R，5R，6S)-5-;2;y^/rojcymef/2;y/-7-^?;c^2Z?/o^do[4.1.0]/z€7?m«e-2，3，4々ib/ 
4.~~To a suspension of palladium-on-charcoal (100 mg, 5% w/w) in absolute EtOH (3 
cm^) under H2 at atmospheric pressure was added a solution of the compound 9 0 
(723.5 mg, 1.62 mmol) in absolute EtOH (25 cm^). The suspension was stirred for 3 
h at room temperature and filtered through a pad of Celite. The residue was washed 
wi th methanol (30 cm^). Concentration of the filtrate followed by flash 
chromatography [chloroform—methanol (3:1 v/v)] gave the (1R,2S,6S)-diastereoisomer 
4 (254.6 mg, 89.2%) as colourless plates, m . p . 129—131。C (MeOH), [ l i t j ^ oil]; Rf 
0.30 [chloroforai-methanol (3:1 v/v)] (Found C, 47.6; H, 6.9. C7H12O5 requires C， 
47.7; H , 6.9); [a ]D23 - 39.5 (c 0.9，H2O), {lit.，i2 一 75 0.1，H2O)}; 
Vmax(KBr)/cm-l 3364, 3426 (OH); 5H (D2O) 2.05 ( IH, m, 5-H), 3.32 ( IH, d, J 3.7), 
3.43 ( IH , t, J 2.9), 3.50-3.60 (2H, m), 3.78 ( IH, dd, J 6.8 and 11.3，8-H), 3.92 
( IH, dd, J 3.7 and 11.3，8,-H)，4.43 ( IH, br s) ； 5c (D2O) 45.3, 55.6’ 56.6, 61.6， 
66.7, 68.0，71.2; m/z (CI) 177 (MH+). 
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(lS,2R，3R，4R>2，3-Z)/_0-Z?e/zz:y/-4-Z7eAiz;y/ar:ywer/2y/-5-c}^d^?/z£jc^-l，2，3-m.o/ 
53.—A solution of the benzoate 78 (198 mg, 0.371 mmol), and a catalytic amount of 
sodium methoxide in anhydrous methanol (8 cm^) was stirred at room temperature for 
12 h. Concentration of the solution followed by addition of diethyl ether (15 cm^) gave 
a pad of inorganic solid which was filtered off through a pad of Celite. Concentration 
of the filtrate followed by flash chromatography [hexane-diethyl ether (3:2 v/v)] gave 
the title compound 53 (149.3 mg, 94%) as colourless needles, m.p, 55.0—56.5 °C; Rf 
0.22 [hexane-diethyl ether (2:1 v/v)] (Found: C，78.4; H，7.0. C28H30O4 requires C, 
78.1; H，7.0%); [(X]D23 + 137.3 (c 0.8); 3450 (OH); 5H 2.16 ( IH, d, 
J 4.83，OH), 2.54-2.62 ( IH, m, 4-H), 3.47-3.57 (2H, m，7-H, 7’-H)，3.62 ( IH, dd, 
J 9.1 and 7.0，2-H), 3.73 ( IH, t, J 9.1，3-H), 4.26-4.32 ( IH , m，1-H), 4.41 and 
4.47 (2H, ABq, J 12.3, 0C//2Ph)，4.50 and 4.86 (2H, ABq, J 11.1，0C//2Ph), 4.73 
and 4.95 (2H, ABq, J 11.6, 0C//2Ph)，5.69 (2H，bs, 5-H, 6-H), 7.21-7.26 (15H, 
m, OCH2尸/z); mh (EI) 339 (M+ - C7H7, 11%), 91 (100). 
(lR，2R，3R，4R)-2，3-Df"0-Z?eA2z:y/-4-Z?e/2z:y/^ ?;c:Km /^zy/-5-c;yd^?/z£x^-l，2，3-/n.(9/ 
54.~Method A. A solution of the allyl acetate 73 (185.6 mg, 0.393 mmol) and a 
catalytic amount of sodium methoxide in anhydrous methanol (10 cm^) was stirred at 
room temperature for 15 h. The mixture was filtered through a pad of silica gel topped 
with Celite and washed with ethyl acetate (20 cm^). Concentration of the filtrate 
followed by flash chromatography [hexane-diethyl ether (1:1 v/v)] gave the title 
compound 54 (160.3 mg, 95%) as a colourless oil; 0.35 [hexane-diethyl ether (1:1 
v/v)]; [a]D28 + 54.3 (c 1.3); 3450 (OH); 5H 2.45-2.53 ( IH, m，4-H), 
2.61 ( IH , br s, OH), 3.44 ( IH, dd, J 9.0 and 6.4，7-H), 3.58 (IH，dd，J 9.0 and 4.3， 
7'-H), 3.65 (IH，dd, J 9.2 and 4.1，2-H), 3.81 ( IH, t, J 9.2，3-H), 4.31 ( IH, br s, 1-
H), 4.22 and 4.48 (2H, ABq, J 12.5, 0C//2Ph), 4.68 and 4.77 (2H, ABq, J 11.7, 
0C//2Ph), 4.51 and 4.88 (2H, ABq, J 11.1，0C//2Ph), 5.82 (2H, br s, 5-H, 6-H), 
7.24-7.36 (15H, m，OCH2尸/O; m/z (EI) 339 (M+ - C7H7, 9%), 91 (100). 
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M 感 d B. A solution of the cyclic sulfate 70 (220 mg, 0.431 mmol), tetrabutyl-
ammonium iodide (191.2 mg, 0.518 mmol) in THF (30 cm^) was heated under reflux 
for 6 h under nitrogen. The solvent was then evaporated and xylene (30 cm^) and 
DBU (0.142 cm3，0.950 mmol) were added to the residue. The solution was heated 
under reflux for 24 h. The solution was cooled and conc. H2SO4 (0.2 cm^) and THF 
(30 cm3) were added and stirred for 1 h. An excess of NaHCO] was added and the 
solution stirred until neutralisation as shown by pH paper. The mixture was filtered 
through a pad of silica gel topped with Celite. Concentration of the filtrate followed by 
flash chromatography [hexane-ethyl acetate (3:1 v/v)] gave the title compound 5 4 
(113.6 mg, 61%) as a colourless oil. 
Method C. To a solution of the compound 77 (181.4 mg, 0.309 mmol) in CH2CI2 
(5 cm3) at - 70 was added MCPBA (125.5 mg, 0.618 mmol) and the solution 
stirred for 10 min and allowed to rise to room temperature. Diisopropylethylamine 
(161 cm3，0.927 mmol) and toluene (5 cm^) was added to the colourless solution and 
heated at 80 °C for 1 h. The yellow solution was poured into an aqueous saturated 
solution of NH4CI (2 cm^). The aqueous phase were extracted with CH2CI2 ( 3 x 3 
cm^). The combined organic extracts were washed with brine ( 2 x 2 cm^), dried 
(MgS04)，and filtered. Concentration of the filtrate followed by flash chromatography 
[hexane-diethyl ether (2:1 v/v)] gave the title compound 54 (96 mg, 72%) as a 
colourless oil. 
(lR,2R,3SA^,5R)-3A-Di-0'benzyl-5-benzyloxymethyl-l,2-0-cyclohexan-
2,3A'tetrol 57.—To a solution of the compound 68 (157 mg, 0.297 mmol) in 
CH2CI2 (5 cm3) was added TFA (2 drops) and H2O (1 drop). The mixture was stirred 
at room temperature for 24 h and poured into an aqueous solution of NaHC03 (5% 
w/v, 1 cm^). The aqueous phase was extracted with CH2CI2 ( 3 x 2 cm^). The 
combined extracts were washed with brine ( 2 x 1 cm^), dried (MgS04)肌d filtered. 
Concentration of the filtrate followed by flash chromatography [hexane-ethyl acetate 
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(2:2.8 v/v)] provided the title compound 57 (120 mg, 90%) as plates, m.p. 
110.5~112。C (hexane-diethyl ether); Rf 0.40 [hexane-ethyl acetate (2:3 v/v)] 
(Found: C’ 75.2; H, 7.2. C28H32O5 requires C，75.0; H, 7.2%); [ a b ^ ^ + 26.3 (c 
1.2); Vmax(film)/cm-l 3450 (OH); 5H 1.63 ( IH, m), 1.83-1.90 (2H，m), 3.45 ( IH, dd, 
J 9.2 and 2.8)，3.50-3.65 (3H, m), 3.70 ( IH , dd, J 10.5 and 9.3)，4.16 ( IH, t，J 
2.75，2-H), 4.47 (2H, s, OCH^Vh), 4.70 (2H, s, 0C//2Ph), 4.50 and 4.86 (2H, 
ABq，J 10.8，0C//2Ph), 7.21-7.61 (15H, m, 0CH2P/i); m/z (EI) 357 (M+ - C7H7, 
5.1%), 91 (100). 
3A-0-Cyclohexylidenequinic acid-l,5-lactone 61 .59_^ niixture of (-)-quinic acid 
58 (100 g, 0.52 mol), and cyclohexanone (152 cm^, 1.56 mol) containing conc. 
phosphoric acid (10 drops) was heated under reflux for 30 min. The solution was then 
distilled for ca. 2.5 h until all water (ca. 9.4 cm^) came out. The yellow solution was 
left to cool and ethyl acetate (160 cm^), potassium hydrogen carbonate (16 g), and 
anhydrous sodium sulphate (16 g) were added. The mixture was stirred until 
neutralisation as shown by pH paper, filtered and the filtrate concentrated to leave a 
yellow solid. Recrystallisation of the solid from chloroform—hexane (1:1 v/v) gave the 
title compound 61 (110 g, 83%) as colourless needles, m.p. 140~142 °C (lit.,58 
1 3 ^ 1 4 1 °C); R^ 0.30 [hexane-diethyl ether (1:2 v/v)]; [aJo^^ - 30.4 (c 1.0) {lit.,^^ 
[(X]D20 - 33 (c 1.1)}; Vmax(film)/cm-l 3425 (OH) and 1797 (lactone C=0); 5H 1.40-
1.75 (lOH, m )，2.18 ( IH , dd, J 14 and 3)，2.34 (2H, m), 2.66 ( IH, d，J 12), 3.04 
[ IH , bs, (OH)], 4.31 ( IH , ddd，J 6’ 2.3 and 1.2), 4.48 ( IH, td, / 7 and 2.85), 4.74 
( IH, dd, J 6 Mid 2.5); m/z (EI) 254 (M+，24%), 211 (M+-C3H7, 100). 
Methyl 3A-0-cyclohexylidenequinate To a solution of the lactone 61 (10.4 
g, 40 mmol) in methanol (60 cm^) was added dropwise a solution of sodium methoxide 
(2.35 g, 43.5 mmol) in methanol (20 cm^) over 20 min at 0 °C. The mixture was 
stirred for 2 h and the pH of the solution was adjusted to 5 with glacial acetic acid. The 
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mixture was diluted with CH2CI2 (100 cm^) and washed with water (2 x 20 cm^), 
brine (2 x 20 cm^), dried (MgSO*), and filtered. Concentration of the filtrate followed 
by flash chromatography [hexane-diethyl ether (1:4 v/v)] provided the title compound 
62 [9.4 g, 87% (based on recovery of the starting lactone, 0.8g, 8%)] as a colourless 
oil，(lit.,53 m.p. 81—82 °C); R^ 0.30 [hexane-diethyl ether (1:4 v/v)]; [aJo^l 一 4i.8 
(c 0.8) { l i t . , [ a ] D - 40.5 (c 5.2, CH2CI2)}; v^^ ( f i lm) /cm- l 3450 (OH) and 1733 
(C=0); 8H 1.40-1.75 (lOH, m), 1.75-2.40 (4H, m), 3.00 ( IH , br s), 3.56 ( IH, br 
s)，3.81 (3H, s), 3.99 ( IH , t，J 6,68), 4.13 ( IH , ddd，J 11, 6.5 and 4.5), 4.47 ( IH, 
dd，J 7.5 and 4.5); miz (EI) 286 (M+’ 29%), 243 (M+ - C3H7, 100). 
Methyl 4，5-0-cyclohexylidene-3-dehydro-4-epishikimate 64.53—To a mixture of 
the diol 62 (2.5 g, 8.7 mmol), 3 A molecular sieves (5 g) and pyridine (2.8 cm^, 26.1 
mmol) in dry CH2CI2 (40 cm^) was added pyridinium chlorochromate (7.5 g, 34.8 
mmol) in one portion at room temperature. The mixture was stirred for 24 h, diluted 
with diethyl ether (100 cm^) and filtered through a pad of Celite. The residue was 
washed with diethyl ether (300 cm^). The combined filtrate were washed with brine (2 
X 50 cm3)，dried (MgSO*)，and filtered. Concentration of the filtrate followed by flash 
chromatography [hexane-diethyl ether (1:1 v/v)] provided the enone 64 (2.0 g，86%) 
as a white solid, m.p. 100。C (lit.,53 m.p. 90—91 °C); 0.34 [hexane-diethyl 
ether (1:1 v/v)]; [aJo^l 一 47 (c LO) {\it.P [ a b - 44 (c 2,1, CH2CI2)}； 
cm-1 1722 (ester C=0) and 1682 (ketone C=0); 5H 1.3-1.7 (lOH, m), 2.87 ( IH, 
ddd, J 20, 4.9 and 2.8)，3.25 ( IH, br d，J 20), 3.86 (3H, br s), 4.30 ( IH, d, J 4.9), 
4.70 ( IH , td, J 4.9 and 1.6)，6.84 ( IH, d, J 2.5); m/z (EI) 266 (M+，20%), 223 ( M + -
C3H7, 100). 
0^R,2R,?^S)-h2-O-Cyclohexylidene-5-hydroxymethyl-4-cychhexen-l,2’:i-triol 
65.54__To a solution of the enone 64 (1.0 g, 3.76 mmol) in dry toluene (12 cm^) was 
added dropwise a solution of D IBAL-H (1.5 M solution in toluene, 7.5 cm^, 11.3 
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mmol) over 30 min at - 40 The mixture was stirred for 1 h at 0 quenched with 
saturated aqueous NH4CI (5 cm^) and filtered through a pad of Celite. The aqueous 
phase was extracted with CH2CI2 (4 x 15 cm^). The combined extracts were washed 
with brine ( 2 x 5 cm^), dried (MgS04)，and filtered. Concentration of the filtrate gave 
an oi l which was flash chromatographed [hexane-diethyl ether (1:4 v/v)] to yield the 
颜 65 (0.78 g, 86%) as a white solid, m.p. 80—82。C ( l i t ” 54 m.p. 67—69 °C); Rf 
0.22 [hexane--diethyl ether (1:4 v/v)]; [afe^S + 3.9 0.8) { l i t”54 [a fe + 3.7 (c 0.8， 
CH2CI2))； Vmax(filni)/cm-l 3400 (OH); 5h 1.21-1.57 (lOH, m), 2.42 ( IH, dd, J 16 
and 2.8), 4.05 (3H, br s), 4.47 ( IH, dd, J 6.5 and 4.4)，4.57 ( IH , ddd, 7 7 , 4 and 
2.8)，5.76 ( IH, br s); m/z (EI) 240 (M+，43%). 
1,2,3-rrw/ 66.52_Sodium hydride (80%, 0.5 g, 15.2 mmol) was washed with dry 
hexane ( 2 x 5 cm^) and suspended in dry THF (10 cm^) under nitrogen at 0 °C. A 
solution of the diol 4 (1.22 g, 5.08 mmol) in THF (5 cm^) was added dropwise and the 
mixture was stirred for 1 h. Benzyl bromide (2.4 cm^, 20.3 mmol) was added 
dropwise followed by the addition of a catalytic amount of tetrabutylammonium iodide. 
The mixture was heated under reflux overnight. Methanol (5 cm^) was then added 
slowly followed by the addition of water (8 cm^). The solvent was removed under 
reduced pressure. Chloroform (30 cm^) was added and the aqueous layer was then 
extracted with chloroform (4 x 10 cm3). The combined extracts were washed with 
brine ( 3 x 5 cm^), dried (MgS04) and filtered. Concentration of the filtrate followed 
by flash chromatography [hexane—diethyl ether (5:1 v/v)] provided the title compound 
66 (1.75 g, 82%) as a colourless oil; 0.23 [hexane-diethyl ether (5:1 v/v)]; [aJo^^ 
+ 28.0 (c 0.8) {lit.，52 [ a ] D + 5.5 (c 0.3，CH2CI2)}； 3000-3100 
(aromatic C—H); 5H 1.27-1.73 (lOH，m), 1.86 ( IH, br d, J 16)，2.42 ( IH, dd, J 16 
and 1.4)，3.82 ( IH , br s), 3.95 and 4.01 (2H, ABq, J 12), 4.44 and 4.56 (2H, ABq, J 
12), 4.50-4.61 (2H，m), 4.69 and 4.79 (2H, ABq, J 12,1), 5.90 ( IH, br s), 7.24-
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7.41 (lOH, m); m丨z (EI) 420 (M+，0.2%), 92 (100). 
(1R,2R,3S AK,5K)-'^0-Ben2yl-5-beiuyloxyrnethyl-12-0-cycbhexylidenecycIohejcan-
l,23A-tetrol 67.52一To ^ solution of the compound 66 (1.5 g, 3.57 mmol) in dry 
THF (15 cm3) was added a solution of borane-methyl sulfide complex (2.0 M solution 
in THF, 1.5 cm^, 3 mmol) at room temperature. The mixture was stirred for 24 h and 
the excess of hydride was carefully destroyed by the slow addition of water (1 cm^). 
The mixture was oxidized by the addition of an aqueous solution of NaOH (3 M , 4 
cm3) and an aqueous solution of H2O2 (30% w/v, 4 cm^) at 0 °C followed by stirring at 
room temperature overnight. The solvent was evaporated and CHCI3 (30 cm^) was 
added to the residue. The aqueous phase was extracted with CHCI3 (3 x 10 cm^). The 
combined organic extracts were washed with brine ( 2 x 5 cm^), dried (MgSO*) and 
filtered. Concentration of the filtrate followed by flash chromatography [hexane-
diethyl ether (3:2 v/v)] provided the title compound 67 (1.3 g, 83%) as colourless 
needles, m.p. 62—63 °C (lit.,52 m.p. 72—72 °C); Rf 0.33 [hexane-Methyl ether (1:1 
v/v)]; [(X]d20 - 12.0 (c 1.0) { l i t . , [ a ] D - 20 (c 0.3，CH2CI2)}； Vmax(film)/cm-l 3460 
(OH); 5H 1.32-1.89 (13H, m), 2.85 ( IH, br d, J 1.3，0H\ 3.35 ( IH, dd, J 9.5 and 
4，3-H), 3.41 ( IH, dd, / 9 . 1 and 6.1，7-H), 3.56 ( IH , dd, J9A and 5.4，7'-H), 3.77 
( IH, t, J 9.5，4-H), 4.00-4.09 ( IH, m, 1-H), 4.27 ( IH , t, J 4，2-H), 4.43 (2H, br s, 
0C//2Ph), 4.63 and 4.72 (2H, ABq, J 12, 0C//2Ph), 120-12A (lOH, m, OCH2尸/O; 
m/z (EI) 438 (M+，50%), 91 (100). 
( IR , 2R，3S，4R’5R)-3，4-D/-0-Z?eA2zy/-5-Z?enz};/^ ?;o7ner/iy/-1，2-0-o^d^?/z ;^cy//^ ieAi^ -
cyclohexan-l,2,3A-tetrol 68.—Sodium hydride (30 mg, 1.04 mmol) was washed 
with dry hexane ( 2 x 1 cm^) and suspended in dry THF (5 cm3) under nitrogen at 0。C. 
A solution of the alcohol 67 (304.5 mg, 0.695 mmol) in THF (2 cm^) was added 
drop wise and the mixture was stirred for 1 h. Benzyl bromide (0.165 cm^, 1.39 
mmol) was added dropwise followed by the addition of a catalytic amount of 
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tetrabutylammonium iodide. The mixture was stirred at 60。C for 12 h. Methanol (1 
cm3) was added slowly followed by the addition of water (3 cm^). The solvent was 
removed under reduced pressure. Chloroform (10 cm^) was added to the residue and 
the aqueous layer was then extracted with chloroform ( 4 x 4 cm^). The combined 
extracts were washed with brine ( 3 x 3 cm^), dried (MgSO-) and filtered. 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(3:1 v/v)] provided the title compound 68 (300 mg, 82%) as a white solid, m.p. 
82.5~83。C (diethyl ether-hexane); Rf 0.31 [hexane-diethyl ether (1:1 v/v)] (Found: 
C，76.9; H, 7.4. C34H40O5 requires C, 77.2; H, 7.6%); [aJo^O + 28.8 (c 1.0); 
Vmax(film)/cm-l 3000-3100 (aromatic C-H); 1.4-2.0 (13H, m), 3.52 (2H, br d, J 
4.3), 3.65 ( IH, dd, J 8.7 and 3.9, 3-H), 3.76 ( IH, t, J 8.7，4-H), 4.06-4.14 ( IH, m, 
1-H), 4.31 ( IH , t, J 4.4, 2-H), 4.47 (2H，s, 0C//2Ph), 4.77 (2H，s, OC/ZsPh)，4.50 
and 4.89 (2H, ABq, J 10.9’ 0C//2Ph), 7.27-7.42 (15H, m, OCHsP/O; miz (EI) 528 
(M+，4%), 437 ( M + - C7H7’ 7)，91 (100). 
(1R, 2R，3 S，4R,5R)-3,4-D i-O-be nzyl-5-benzyloxyme thyl-1,2-sulfite-cyclohexan-
lX3A-tetrol 69.—To a solution of the diol 57 (223.7 mg, 0.50 mmol), triethylamine 
(0.28 cm3，2 mmol) in CH2CI2 (10 cm^) at 0。C was added thionyl chloride (0.054 
cm3, 0.75 mmol) over 5 min. The reaction mixture was diluted with cold ether (25 
cm3) and washed with cold water ( 2 x 1 5 cm^) and brine (15 cm^), dried (MgS04) and 
filtered. Concentration of the filtrate followed by flash chromatography [hexane-diethyl 
ether (1:1 v/v)] provided the title compound 69 (230 mg, 93%) as colourless needles, 
m.p. 99.5—102。C; 0.40 [hexane-dither ether (1:1 v/v)]; [aJo^^ + 62.3 (c 0.5); 
Vmax(film)/cm-l 1211 (S=0) and 810-850 (S-O-C); 5h 1.69-1.82 (2H, m), 2.16-2.23 
( IH , m), 3.48-3.55 (2H, m)，3.72 ( IH, t, J 7.8)，4,85 ( IH, dd, J 73 and 3.7), 4.44 
(2H, s), 4.48 ( IH, d，J 11)，4.68 ( IH, d, J 11.8)，4.76 ( IH, d, J 10.4)，4.77 ( IH, d, 
J 10.8)，4.87-4.93 ( IH, m), 5.14 ( IH, t, J 4.6)，7.21-7.36 (15H, m); m/z (EI) 403 
(M + - C 7 H 7 , 4%), 91 (100). 
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(1R’ 2R，3S，4 R，5R)-3 ’ 4-D/-0-办伙 2>；/-5 -办伙 z y 1 ， 2 - 似 / / a r e 
I X X ^ - t e t r o l 70.—To a solution of the diol 57 (88 mg, 0.198 mmol), triethylamine 
(0.110 cm3, 0.792 mmol) in CHsCl? (5 cm^) at 0。C was added thionyl chloride (0.05 
cm，0.69 mmol) over 5 min. The reaction mixture was diluted with cold ether (12 ‘ 
cm3) and washed with cold water (2 x 12 cm^) and brine (10 cm^). The organic 
solution was dried (MgSO*) and filtered. The solvent was removed under reduced 
pressure and the residual triethylamine was remover under reduced pressure (ca. 1 h). 
The solid residue was dissolved in CCI4 (5 cm^) and CH3CN (5 cm^), and the solution 
cooled in an ice-bath. Cold water (8 cm^) was added followed by a catalytic amount of 
RUCI3.H2O and NaI04 (85 mg, 0.396 mmol). After 1 h, diethyl ether (15 cm^) w a s " “ 一 
added and the two layers were separated. The aqueous layer was extracted with diethyl 
ether ( 2 x 5 cm^) and the combined organic extracts were washed with brine ( 2 x 5 
cm3)，dried (MgS04) and filtered. Concentration of the filtrate followed by flash 
chromatography [hexane-diethyl ether (2:3 v/v)] provided the title compound 70 (89.9 
mg, 89%) as a white solid, m.p. 106.5—108 R^ 0.35 [hexane-dither ether (2:3 
v/v)] (Found: C, 65.65; H, 5.75. C28H30O7S requires C, 65.9, H, 5.9%); [aJo^O + 
27.8 (c 0.9); Vmax(film)/cm-l 1210 (S=0) and 810-850 (S-O-C); 5H 1.61-1.68 ( IH, 
m)，2.13-2.35 (2H, m), 3.49 (2H, d, J 5.0), 3.69-3.77 (2H，m), 4.45 (2H, s), 4.45 
( IH , d, J 10.9), 4.70 (IH，d, J 11.8)，4.73 ( IH, d, J 12.6)，4.78 ( IH, d，J 12.0), 
4.86-4.95 ( IH , m), 5.09-5.11 ( IH, m)，7.17-7.37 (15H, m); mh (EI) 419 ( M + -
C7H7, 9%), 91 (100). 
(lR，2R，3R，4S’6R)-l，2-I)/-0-Z?e/2z;y/-6-Z?e«z;y/<9;c:ym&/z;y/-4-z.^?^i(9-c:yd<9/i6^/ie-
l，2，3-rr/o/ 7 1 . ~ A solution of the cyclic sulfate 70 (127 mg, 0.249 m m o l ) ,舰 4 N I 
(110 mg, 0.299 mmol) in THF (12 cm^) was heated under reflux for 6 h under 
nitrogen. Conc. H2SO4 (0.015 cm^) and H2O (0.004 cm^) were added and the 
solution stirred for 30 min at 60 An excess of NaHCOg (100 mg) was added and 
the mixture stirred for 25 min. The mixture was filtered through a pad of silica gel 
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topped with Celite and washed with CH2CI2. Concentration of the filtrate followed by 
flash chromatography [hexane-diethyl ether (3:1 v/v)] afforded the title compound 7 1 
as a colourless oi l (116 mg, 83%); /?f0.60 [hexane-diethyl ether (1:1 v/v)] (Found: C, 
60.5; H，5.5. C28H31O4I requires C, 60.2; H, 5.6%); [a]^ '^^ + 46.4 (c 1.4); 
Vmax(film)/cm-l 3440 (OH); 5h 1.8-2.3 (3H, m), 2.73 ( IH , d, J 2.05, OH), 3.47 
(IH，dd, J 9.1 and 2.9, 7-H), 3.67 ( IH, dd, J 9.1 and 4.9，7’-H)’ 3.78 ( IH , t, J 8.7， 
1-H)’ 4.14 ( IH , dd, J 8.7 and 2.9, 2-H), 4.20 ( IH, br s, 3-H), 4.3-4.53 (4H, m, 4-
H，0C//2Ph), 4.60 and 4.69 (2H, ABq, J 11.4，0C//2Ph), 4.79 ( IH , d，/ 10.9， 
0C//2Ph), 7.21-7.41 (15H, m, OCH:尸A); m/z (EI) 558 (M+，2%), 467 (M+ - C7H7, 
32), 91 (100). -
(lR，2R，3R’4S’6R)-3-O-Ace0^/-l，2-^//"O-Z7e«z:y/-6-Z?eAzz:y/o:*:;ym^/z;y/-4-/o^it?-
cyclohexan-\X^-triol 72.—To a mixture of the iodo alcohol 71 (669.4 mg, 1.20 
mmol), pyridine (0.213 cm^, 2.64 mmol), and a catalytic amount of DMAP in dry 
CH2CI2 was added acetic anhydride (0.125 cm , 1.32 mmol) at room temperature. 
The solution was stirred at room temperature for 24 h and poured into a solution of 
saturated aqueous NH4CI (8 cm^). The aqueous phase was extracted with CH2CI2 (2 
X 8 cm3). The combined organic extracts were washed with brine ( 2 x 8 cm�)，dried 
(MgS04)，and filtered. Concentration of the filtrate followed by flash chromatography 
[hexane-diethyl ether (3:1 v/v)] afforded the title compound 72 ( 680.5 mg, 94.5%) as 
a colourless oil; Rf 0.55 [hexane-diethyl ether (2:1 v/v)] (Found: C, 60.1; H, 5.4. 
C30H33O5I requires C，60.0; H, 5.5%); [aJo^^ + 59.5 (c 1.2); cm'^ 1744 
(C=0); 5H 2.13 (3H, br s), 2.04-2.19 (3H, m), 3.50 ( IH, dd，/ 9.1 and 2.9，7-H), 
3.70 ( IH , dd, J 9.1 and 4.9, 7'-H), 3.75 ( IH, t, J 9.0，1-H), 4.29 ( IH, dd，J 9.0 and 
3.5, 2-H), 4.43-4.50 (3H, m, 0C/ /2Ph) , 4.55 and 4.65 (2H, ABq, J 11.2, 
0C//2Ph), 4.83 ( IH, d, J 10.9，0C//2Ph), 5.19 ( IH, t, / 3.5, 3-H), 7.22-7.35 (15H, 
m，OCH2尸/O; m/z (EI) 509 (M+ - C7H7, 13%), 493 (M+ - C7H7O, 23), 403 (M+ -
C7H7 - C7H6O, 46)，91 (100). 
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(lR，2R，3R，4R)-l-O-Ace0 /^-2，3- /^/"O-Z?6«z3 /^-4-Z?《Aiz:y/^ ?;c}7w&/i:y/-5-C7do/z ;^ceAi-
1,2,3-rno/ 7 3 . — A solution of the iodo acetate 72 (1.15 g, 1.92 mmol), 1,8-
diazabicyclo[5.4.0]-undec-7-ene (DBU) (0.57 cm^, 3.83 mmol) in xylene (25 cm^) 
was heated with reflux under nitrogen for 12 h. The mixture was cooled and filtered 
through a pad of silica gel topped with Celite and washed with diethyl ether (30 cm^). 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(5:2 v/v)] gave the title compound 73 (0.75 g, 83%) as a colourless oil; Rf 0.48 
[hexane-diethyl ether (2:1 v/v)] (Found: C, 76.5; H, 6.7. C30H32O5 requires C, 
76.25; H，6.8%); [ab〗〗 -19.7 (c 1.2); Vn,^(film)/cm-l 1735 (C=0); 5H 2.11 (3H， 
br s, Ac), 2.50 ( IH , m，4-H), 3.50 ( IH, dd, J 9.0 and 6.0，7-H), 3.61 ( IH, dd, J 9,0 
and 4.0，7’-H)，3.73 ( IH , dd, J 9.7 and 3.7，2-H), 3.82 ( IH , t, J 9.7，3-H), 4.40-
4.63 (4H, m, 0C/ /2Ph) , 4.72 ( IH, d, J 11.5，0C//2Ph), 4.92 ( IH , d, J 11.0, 
0C//2Ph), 5.67 ( IH , dd, J 4.8 and 3.2, 1-H), 5.76 ( IH, ddd，J 9.6，4.8 and 2.6, 6-
H), 5.93 ( IH , dd, J 9.6 and 2.3，5-H), 7.21-7.33 (15H, m, OCH�？/^); m/z (EI) 381 
(M+ - C7H7, 9%), 275 (M+ - C7H7 一 C7H5O, 32), 91 (100). 
{V^,2R,3RA^.^^)-l,2-Di-0-benzyl-6-benzyloxymethyl-A-phenylseleno-
cyclohexan-1,2,3-triol 7 7 . D i p h e n y l diselenide (9.5 mg, 0.030 mmol) was dissolved 
in absolute ethanol (4 cm^) and sodium borohydride (2.3 mg, 0.061 mmol) was then 
added under nitrogen at 0 Cyclic sulfate 54 (25.9 mg, 0.051 mmol) in THF (2 
cm3) was added and the solution stirred for 2 h at 0 Cone. H2SO4 (0.06 cm^) and 
water (0.04 cm^) were then added and the solution stirred for 2 h. Anhydrous NasCOg 
was added with stirring until neutralisation as shown by pH paper. The mixture was 
filtered through a pad of silica gel topped with Celite. Concentration of the filtrate 
fol lowed by flash chromatography [hexane-diethyl ether (2:1 v/v)] gave the title 
compound 77 (23.8 mg, 80%) as a colourless oil; Rf^  0.50 [hexane-diethyl ether (1:1 
v/v)] (Found: C, 69.2; H, 6.05. C34H3604Se requires C, 69.5; H, 6.2%); [a j^^^ + 
12.4 (c 1.7); Vmax(film)/cm-l 3450 (OH); 5h 1.93 ( IH, dt，J 14.1 and 3.3), 2.08-2.12 
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(IH，m), 2.29—2.37 (IH，m), 2.68 ( IH , d, J 1.6, OH), 3.50 ( IH , dd, J 9.1 and 3.2， 
7-H)，3.62-3.67 (2H，m, 4-H，7’-H)，3.74 ( IH , t，J 9.0，1-H), 4.02 ( IH, dd, / 9 . 0 
and 3.0，2-H), 4.11 ( IH , br s, 3-H), 4.41 and 4.47 (2H, ABq, J 12.2, 0C//2Ph), 
4.51 and 4.80 (2H, ABq, ] 10.9，OC/ZsPh)，4.61 and 4.69 (2H, ABq, J 11.5， 
0C//2Ph), 7.21-7.50 (20H, m, OCH2尸/：，SeP/z); m/z (EI) 558 (M +，10%), 497 (M+ 
一 C7H7, 3.1), 391 (M+ - C7H7 一 C7H7O, 15)，91 (100). 
(1S, 2R,3R，4R)-l-0-5e"zc?;y/-2，3-^i/-0-Z?e«z7/-4-Z?e«z;y/<9JC7m^/2;y/-5 
\X^-triol 7 8 . A solution of the allylic alcohol 54 (589.7 mg, 1.37 mmol), triphenyl 
phosphine (539.6 mg, 2.06 mmol), and benzoic acid (251.2 mg, 2.06 mmol) in 
toluene (20 cm^) was stirred under nitrogen at 0 °C for 15 min. Diisopropyl 
azodicarboxylate (0,459 cm�，2.26 mmol) was added dropwise over 10 min and the 
yellow solution was stirred for 30 min at room temperature. Concentration of the 
solution gave a yellow oil which was flash chromatographed [hexane-diethyl ether (8:1 
v/v) followed by hexane-diethyl ether (5:1 v/v)] to give the title compound 78 (680.0 
mg, 93%) as colourless needles, m.p. 54.5~55.5 0.30 [hexane-diethyl ether 
(5:1 v/v)] (Found: C，78.4; H, 6.4. C35H34O5 requires C, 78.6; H, 6.4%); [aJo^^ + 
215.6 (c 1.2); Vmax(film)/cm-l 1718 (C=0); 5H 2.63 ( IH , m, 4-H), 3.50-3.65 (2H, 
m，H-7, H-7'), 3.81 ( IH , t, J 9.8, 3-H), 3.99 ( IH, dd, J 9.8 and 8.0，2-H), 4.42 and 
4.48 (2H, ABq, J 12.2, OC/ZsPh), 4.76 and 4.86 (2H, ABq, J 11.3，0C//2Ph), 4.50 
and 4.92 (2H, ABq, J 11.0，OC/Z^Ph)，5.66 ( IH, ddd, J 10.0，2.5 and 2.35, 5-H), 
5.77，(IH, br d, J 10，6-H), 5.83 ( IH , m, 1-H), 7.14-8.01 (20H，m, OCH2尸/1， 
OCOP/i); mJz (EI) 443 (M+ - C7H7, 19%), 337 (M+ - C7H7 一 C7H5O, 32), 91 (100). 
(1S，2R’3R，4S，5R，6R)- and (1 R,2S,3R,4S ,5RMy2>-0-Benzoyl-A,5-di-0-benzyl-
6-benzyloxymethyl' 1,2-epoxy-cyclohexan-3 A.5-triol 79a and 79b.~To a solution of 
the alkene 78 (231 mg, 0.433 mmol) in CH2CI2 (10 cm^) was added MCPBA (112.0 
mg, 0.649 mmol) at room temperature. The mixture was stirred at room temperature 
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for 48 h and diluted with CH2CI2 (10 cm^). The solution was washed with an aqueous 
solution of NaOH (0.75 M, 8 cm^). The aqueous phase was then extracted with 
CH2CI2 ( 3 x 8 cm3). The combined organic extracts were washed with brine ( 2 x 8 
cm )，dried (MgS04)，and filtered. Concentration of the filtrate followed by flash 
chromatography [hexane-diethyl ether (3.5:1 v/v)] gave an inseparable mixture of 
diastereomeric oxiranes 79a and 79b (156.2 mg, 65.6%) as a semi-solid. 
(lS，2R，3S’4RJR，6R)-and(lFUFUS，4R，5R，6S)-3，4"D/-O-Z?《n2};/-5-Z?^z};/^?j077Z£%/-
l'0xabicycl0[A. 1 .Q]heptane-2,?>A-triol 80 and Method A. To the inseparable 
diastereoisomeric mixture of oxiranes 79a and 79b (150.2 mg, 0.273 mmol) in 
anhydrous methanol (15 cm^) was added a catalytic amount of anhydrous potassium 
carbonate. The mixture was stirred at room temperature for 15 h. Concentration of the 
solution followed by flash chromatography [hexane-diethyl ether (1:1 v/v)] gave 80 
(31.1 mg, 25.5%) and then 81 (84.8 mg, 69.5%), both as white solids. Compound 
80; m.p. 76.5—78.5。C; 7?f0.50 [hexane-diethyl ether (1:2 v/v)] (Found: C, 75.3; H, 
6.8. C28H30O5 requires C，75.3; H, 6.8%); [aJo^^ + 111.1 (c 0.4); 
3380 (OH); 5H 2.26 ( IH, d，J 3.8, OH), 2.32 ( IH, m，5-H), 3.12 ( IH, d，J 3.6)， 
3.27 ( IH , dd, J 9.6 and 9.1, 7-H), 3.37 ( IH, dd, J 9.6 and 7.6，7’-H)，3.44 ( IH, m, 
2 - H ) , 3 .59 ( I H , t，J 8 .8 , 4 - H ) , 3 .73 ( I H , dd , J 8.8 and 3.9, 3 - H ) , 3 .91 ( I H , dd，J 
7.5 and 3.6), 4.50 and 4.56 (2H, ABq, J 12.2，0C//2Ph), 4.43 and 4.81 (2H, ABq, J 
10.9, 0C//2Ph), 4.67 and 4.92 (2H, ABq, J 11.7, 0C//2Ph), 7.18-7.36 (15H, m, 
OCH2FA)； rrUz (EI) 355 (M+ - C7H7, 71%), 91 (100). 
Compound 81; m.p, 112.5~113.0 Rf 0.42 [hexane-diethyl ether (1:2 v/v)] 
(Found: C, 75.6; H, 6.9. C28H30O5 requires C, 75.3; H, 6.8%); [afe^^ + 86.4 (c 
0.6); Vmax(film)/cm-l 3350 (OH); 5h 2.26 ( IH, d，J 4.8，OH), 2.22-2.27 ( IH, m, 5-
H), 3.19 ( IH , d，J 4.0, 1-H), 3.38 ( IH, dd, J 4.0 and 1.8’ 6-H), 3.46-3.66 (4H, m, 
V 
3-H, 4-H, 7-H, 7,-H)，3.97-4.03 ( IH, m, 2-H), 4.36 and 4.45 (2H, ABq, J 12.1, 
0C//2Ph), 4.42 and 4.84 (2H, ABq, J 11.2，OO/sPh)，4.70 and 4.93 (2H, ABq, J 
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11.4，Oa/2Ph), 7.18-7.35 (15H, m，OCH2尸/i); mJz (EI) 355 (M+ - C7H7, 16%), 91 
(100). 
Method B, To a solution of the epoxide 83 (279.1 mg, 0.498 mmol) in dry THF 
(6 cm3) was added tetrabutylammonium fluoride (1.0 M solution in THF, 0.548 cm^, 
0-548 mmol). The mixture was stirred at room temperature for 10 min, filtered through 
a pad of silica gel topped with Celite, and washed with diethyl ether (30 cm^). 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(1:1 v/v)] afforded the title compound 80 (208.9 mg, 94.0%) as a white solid. 
Method B. To a solution of the epoxide 84 (211.1 mg, 0.377 mmol) in dry THF 
(8 cm3) was added tetrabutylammonium fluoride (1.0 M solution in THF, 0.42 cm^, 
0.420 mmol). The mixture was stirred at room temperature for 45 min, filtered through 
a pad of silica gel topped with Celite, and washed with ethyl acetate (25 cm^). 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(1:1 v/v)] afforded the title compound 81 (158.5 mg, 94.3%) as a white solid. 
Method C. To a solution of the allylic alcohol 53 (80.9 mg, 0.198 mmol) in 
CH2CI2 (10 cm3) was added MCPBA (97.4 mg, 0.564 mmol) at room temperature. 
The mixture was heated under reflux for 36 h and poured into a solution of NaOH 
(0.75 M，3 cm3). The aqueous phase was extracted with CH2CI2 ( 3 x 6 cm^) and the 
combined extracts were washed with brine ( 2 x 4 cm^), dried (MgSO^), and filtered. 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(1:1 v/v)] gave 80 (3.7 mg, 4.4%) and then 81 (55.8 mg, 66%), both as white solids. 
(1S，2S，3R,4S )-2，3-I) f 1 - 0 - t e r t - Z ? 
cyclohexen-1,2,3-triol 83.—A solution of the allylic alcohol 53 (541.6 mg, 1.26 
mmol), imidazole (428,7 mg, 6.30 mmol), TBDMSCl (664 mg, 3.78 mmol), and a 
catalytic amount of DMAP in dry DMF (12 cm^) was stirred at room temperature for 9 
h. Water (10 cm^) and diethyl ether (20 cm^) were added and the aqueous phase was 
extracted with diethyl ether (3 x 10 cm^). The combined organic extracts were washed 
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with brine ( 2 x 8 cm^), dried (MgSO*) and filtered. Concentration of the filtrate 
followed by flash chromatography [hexane-^ethyl ether (12:1 v/v)] provided the title 
compound 82 (624.9 mg, 91.2%) as a colourless oil; Rf 0.37 [hexane-<iiethyl ether 
(12:1 v/v)] (Found: C’ 75.3; H, 8.3. €3411440451 requires C, 75.0; H，8.1%); [aJ^^S 
+ 120.0 (c 0.3); Vmax(filni)/cm-l 3000-3100 (aromatic C -H ) ; 0.09 (3H, s, SiM己)， 
0.11 (3H, s，SiMeX 0.91 (9H, s’ ⑦w), 2.55 ( IH , m, 4-H), 3.50 (2H，br d，J 4.1，7-
H，7’-H)，3.61-3.65 (2H, m, 2-H，3-H), 4.36-4.48 (4H, m, 1-H, 0C//2Ph), 4.86 
( IH , d, J 11.2, 0C//2Ph), 4.89 (2H, br s, OCH^Vh), 5.53 ( IH , dt, J 2.0 and 10.5) 
and 5.59 ( IH , dt，J 1.5 and 10.5) 5-H and 6-H, 7.12-7.34 (15H, m, OCH2P/O; rniz 
(CI) 544 (M+’ 4%), 453 (M+ - C7H7, 5), 438 (M+ 一 CvH^O, 3)，91 (100). 
(1R，2S，3S，4R，5R，6R)- and (lS，2S，3S，4R，5R，6S)-3’4-D/-0-6^zy/-5-Z?^g/a<^m r^/z>7-
2-0-ten-butyldimethylsUyl-7-oxabicyclo[4.LQ]heptane-2,?fA-triol83 and 84.—To a 
solution of the alkene 82 (624.9 mg, 1.15 mmol) in CH2CI2 (15 cm^) was added 
MCPBA (595 mg, 3.45 mmol) at room temperature. The mixture was heated under 
reflux for 40 h and poured into an aqueous solution of Na2C03 (10% w/v, 5 cm^). 
The aqueous phase was extracted with CHCI3 (3 x 10 cm^). The combined organic 
extracts were washed wi th brine ( 2 x 5 cm^), dried (MgS04) and filtered. 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(10:1 v/v)] provided firstly the less polar title compounds 83 (281.7 mg, 43.8%) 
which was followed by 84 (179.0 mg, 27.8%), both as colourless oils. Compound 
83; /^f 0.44 [hexane-diethyl ether (6:1 v/v)] (Found: C, 72.9; H, 7.9. C34H4405Si 
requires C, 72.8; H, 7.9%); [ a j p ^ ^ + 62.6 (c 1.2); Vmax(film)/cm-l 3000-3100 
(aromatic C-H); 5H 0.10 (3H, s, SiMe), 0.17 (3H, s, S\Me\ 0.93 (9H, s, 2.30 
( IH , m，5-H), 3.04 ( IH , d，J 3.60’ 6-H), 3.22 ( IH, t, J 10.0，4-H), 3.39 ( IH, dd，J 
10.0 and 7.8, 3-H), 3.44 ( IH , br d, J 3.2，1-H), 3.56 ( IH, t, J 8.8，7-H), 3.73 (IH， 
dd, J 8.8 and 3.5，7,-H)，4.00 ( IH , d，J 7.8, 2-H), 4.35 (IH，d, J 10.0，0C//2Ph), 
4.51 (2H, b r s, OCH^Ph)’ 4.74-4.81 (3H, m, OC/ZsPh)，7.08-7.32 (15H, m, 
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0CH2尸/O; mJz (EI) 469 (M+ - C7H7, 3%), 91 (100). 
Compound 84; /?f0.31 [hexane-diethyl ether (6:1 v/v)] (Found: C, 72.8; H, 8.0. 
C34H4405Si requires C, 72.8; H, 7.9%); [aJo^B + 67.3 (c 1.5); Vmax(mm)/cm-l 
3000-3100 (aromatic C - H ) ; 知 0.09 (3H，s，S\Me), 0.17 (3H，s, S\Me), 0.94 (9H, s， 
⑦w)，2.22 ( IH , m，5-H), 3.16 ( IH , d, J 4.0，6-H), 3.24 ( IH , dd, J 4.0 and 1.9, 1-
H)，3.41-3.60 (4H, m，3-H, 4-H，7-H，7'-H), 4.09 ( IH , dd, J 8.0 and 1.9，2-H), 
4.36 ( IH , d，J 11.1，0C//2Ph)，4.45 and 4.37 (2H, ABq, J 12.2, 0C//2Ph), 4.77-
4.87 (3H, m, 0C//2Ph), 7.08-7.36 (15H, m, OCH2尸A); m/z (EI) 469 (M+ 一 C7H7, 
6%)’ 363 (M+ - C7H7 - C7H6O, 6)，91 (100). 
(1R，2S ,3S ,4R,5R,6R)-2,3 A-Tri<>cre:yI-5-a:eiox)meihyl-7-QxaMcyclo[4.1.0]hq?tme-
2,3A-triol 85 .—A solution of cyclophellitol 1 (17.4 mg, 0.099 mmol), acetic 
anhydride (0.3 cm^), and a crystal of DMAP in pyridine (1.5 cm^) was stirred at room 
temperature for 12 h. The solution was diluted with CH2CI2 (4 cm^) and an aqueous 
saturated solution of NH4CI (1.5 cm^) was added. The aqueous phase was extracted 
with CH2CI2 ( 4 x 4 cm3) and the combined organic extracts were washed with brine 
( 2 x 4 cm3)，dried (MgS04)，and filtered. Concentration of the filtrate foUwed by flash 
chromatography [hexane-diethyl ether (1:2 v/v)] gave the tetraacetate 85 (31.0 mg, 
91%) as colourless needles, m.p. 105~106。C; /?f0.44 [hexane-diethyl ether (1:3 
v/v)] (Found C, 52.0; H, 5.8. C15H20O9 requires C, 52.3; H, 5.85%); [ajjy^^ + 100 
(c 0.2); Vmax(film)/cm-l 1752 (C=0); 5h 1.99 (3H, s，Ac), 2.04 (3H, s, Ac), 2.09 
(3H, s, Ac), 2.10 (3H, 3s，Ac), 2.50 (IH, m, 5-H), 3.15 (IH, d, J 3.5，1-H), 3.46 
( IH , br d，J 3.5, 6-H), 4.16 ( IH, dd，J 7.3 and 11.3，8-H), 4.31 ( IH, dd, J 4.2 and 
11.3, 8'-H), 5.02 (IH, t，J 10，4-H), 5.0-5.19 (2H, m, 2-H, 3-H); 8c 20.5 (x 2)， 
20.7 (X 2), 39.8, 53.2, 54.7, 62.1, 66.5, 71.1，72.4, 169.6’ 169.7，169.9，170.5; 
m/z (EI) 345 (MH+，6%), 182 (13)，43 (100). 
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(lS，2S^3S，4R^5R，6S)"23，4-7>f-O-ace0^/-5"a:erax:y/we%/-7-o;a2M0^db[4.1 Q^heptane-
2,3A-triol 86.—A solution of the epoxide 2 (10.0 mg, 0.057 mmol), acetic anhydride 
(0.3 cm3)’ and a crystal of DMAP in pyridine (1.5 cm^) was stirred at room 
temperature for 24 h. The solution was diluted with CH2CI2 (4 cm^) and an aqueous 
saturated solution of NH4CI (2 cm^) was added. The aqueous phase was extracted 
with CH2CI2 ( 4 x 4 cm3) and the combined organic extracts were washed with brine 
( 2 x 4 cm3), dried (MgSO*)，and filtered. Concentration of the filtrate foUwed by flash 
chromatography [hexane-diethyl ether (1:2 v/v)] gave the tetraacetate 86 (16.2 mg, 
83%) as a colourless oil; Rf 0.43 [hexane-diethyl ether (1:3 v/v)] (Found C, 52.1; H, 
6.0. C15H20O9 requires C, 52.3; H, 5.85%); [aJo^l + 90.4 (c 0.7); 
1748 (C=0); 5H 2.00 (3H，s, Ac), 2.03 (3H, s, Ac), 2.11 (3H, s, Ac), 2,12 (3H, 3s, 
Ac), 2.52 ( IH , m，5-H), 3.22 ( IH , d，J 3.9，6-H), 3.49 ( IH , dd, J 1.6 and 3.9, 1-H), 
4.11 ( IH , dd，J 5.2 and 11.7，8-H), 4.22 ( IH , dd, J 3.4 and 11.7, 8'-H), 5.07 ( IH, 
dd，J 9.9 and 12.0，4-H), 5.27 ( IH , dd, J 9.1 and 9.9，3-H), 5.34 ( IH, dd，J 1.8 and 
9.1，2-H); 5c 20.5 (X 2)，20.6，20.7, 40.4，53.5, 54.2, 62.2，68.7，70.1, 71.4, 
169.5, 169.8，170.4，170.5; m/z (EI) 345 (MH+，6%), 182 (40)，43 (100). 
(1R,2S,3S,4S,5R,6R)- and (ISAS.5RM)-3-0-Acety 1-4,5-di-0-benzyl-6-
benzyloxymethyl-1,2-epoxy-cyclohexan-3A,5-triol 87 and 88 .~To a solution of the 
allyl acetate 73 (L507g, 3.19 mmol) in CH2CI2 (50 cm^) was added MCPBA (1.38 
g, 7.80 mmol) at room temperature. The mixture was heated under reflux for 42 h and 
poured into an aqueous solution of NaOH (0.75 M, 20 cm^). The aqueous phase was 
extracted with CH2CI2 ( 3 x 1 5 cm^). The combined organic extracts were washed 
with brine (2 x 15 cm^), dried (MgS04)，and filtered. Concentration of the filtrate 
fol lowed by flash chromatography [hexane-diethyl ether (3:1 v/v) followed by 
hexane-diethyl ether (2:1 v/v)] gave initially the less polar title compound 88 (663.3 
mg, 42.6%) as a colourless oi l which was followed by 87 (535.4 mg, 34.4%) as a 
white solid; Compound 87; m.p. 59—61。C; R^ 0.36 [hexane-ethyl acetate (3:1 v/v)] 
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(Found: C, 73.8; H，6.5. C30H32O6 requires C, 73.75; H, 6.6%); [ah^^^ + 4.8 (c 
2.7); Vmax(film)/cm-l 1738 (C=0); 5h 2.16 (3H, s，Ac), 2.33 ( IH, m, 6-H), 3.41 
(IH，t, J 4.0)，3.47-3.54 (2H, m), 3.58 ( IH, dd, J 8.6 and 4.8), 3.67 ( IH, t，J 8.7), 
3.76 (IH，dd, J 8.9 and 5.0)，4.41 and 4.75 (2H, ABq, J 11.1，0C//2Ph), 4.50 and 
4.56 (2H, ABq, J 12.3，0C//2Ph), 4.53 and 4.60 (2H，ABq, J 11.7，0C//2Ph), 5.50 
(IH，t, J 4.6，3-H), 7.19-7.35 (15H, m, OCH2尸/z); m/z (EI) 397 (M+ - C7H7, 
7 . 4 % )， 2 9 1 (M+ - C7H7 一 CyH^O, 29), 91 (100). 
Compound 88; Rf 0.52 [hexane-ethyl acetate (3:1 v/v)] (Found: C, 74.1; H, 6.8. 
C30H32O6 requires C, 73.75; H, 6.6%); [a j^^^ + 143 (〔 2.O); Vmax(mm)/cm-l 1747 
(C=0); 5H 2.16 (3H, s, Ac), 3.29 ( IH, m, 6-H)，[3.21 ( IH, d, J 3.4) and 3.27 ( IH, 
t，J 3.1)，H-1 and H-2], 3.56 ( IH, dd, J 9.3 and 5.4’ 7-H), 3.63 ( IH, dd, J 9.3 and 
3.6，7,-H)，3.67-3.78 (2H, m, 4-H, 5-H), 4.38 and 4.51 (2H, ABq, J 12.1， 
0C//2Ph), 4.41 and 4.83 (2H, ABq, J 11.2，0C//2Ph), 4.53 and 4.68 (2H, ABq, J 
11.2’ 0C//2Ph), 5.84 ( IH, br s, 3-H), 6.98-7.37 (15H, m，OCH2尸/z); m/z (EI) 397 
(M+ - C7H7, 7%), 291 (M+ - C7H7 一 CyH^O, 72), 91 (100). 
(IS，2S 3 S，4R3R^6R)-3，4-Z)i^O-ie«z:y/-5"Z?mz:yte;y^f/?y/-7-a^a&/0^cM4.10]hq)me-
2,3A-triol 89.~Method A. A solution of the epoxy acetate 87 (111.4 mg, 0.228 
mmol), and a catalytic amount of anhydrous potassium carbonate in dry methanol (5 
cm3) was stirred at room temperature for 12 h. Concentration of the solvent followed 
by flash chromatography [hexane-diethyl ether (2:3 v/v)] gave the title compound 89 
(95.8 mg, 94%) as a white solid, m.p. 78~~80。C; Rf 0.36 [hexane-diethyl ether (1:2 
v/v)] (Found: C, 74.9; H, 7.0. C28H30O5 requires C, 75.3; H, 6.8%); [a l^^^ + 42.1 
(c 0.8); Vmax(film)/cm-l 3450 (OH); 5h 2.29-2.34 ( IH, m), 2.65 ( IH, br d，J 6.0), 
3.38 ( IH , t, J 4.0), 3.47-3.58 (3H, m), 3.62-3.74 (2H, m), 3.66 ( IH, t, J 8.9)，3.71 
( IH , dd, J 8.9 and 5.6), 4.27 ( IH, m), 4.48 and 4.55 (2H, ABq, J 12.1), 4.59 and 
4.62 (2H, ABq, J 11.9)，4.43 and 4.71 (2H, ABq, J 11.3), 7.20-7.35 (15H, m); m/z 
(EI) 355 (M+ - C7H7, 19%), 249 (M+ - C7H7 - C7H6O, 9)，91 (100). 
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Method B. To a solution of the epoxide 92 (15.2 mg, 0.027 mmol) in dry THF (2 
cm ) was added tetrabutylammonium fluoride (1.0 M solution in THF, 0.033 cm^, 
0.03 mmol). The mixture was stirred at room temperature for 2 h. Concentration of 
the solvent followed by flash chromatography [hexane-diethyl ether (1:2 v/v)] afforded 
the title compound 89 (11.1 mg, 92%) as a white solid. 
Method C. To a solution of the allylic alcohol 54 (283.8 mg, 0.660 mmol) in 
CH2CI2 (15 cm3) was added MCPBA (285.0 mg，1.65 mmol) at room temperature. 
The mixture was stirred at room temperature for 23 h and poured into an aqueous 
solution of NaOH (0.75 M, 8 cm^). The aqueous phase was extracted with CH2CI2 (3 
X 15 cm3). The combined extracts were washed with brine (2 x 10 cm^), dried 
(MgS04)，and filtered. Concentration of the filtrate followed by flash chromatography 
[hexane-diethyl ether (2:3 v/v) gave the title compound 89 (279.9 mg, 95%) as a 
white solid. 
(1R,2S 3S，4RjR^6S)-3，4-Di"0-Z3e«z;y/-5"6^z;yte:y//2e%/-7-at^2&/0^db[4. LO]h£ptane' 
2,3A-triol 90.~Method A, A solution of the epoxy acetate 88 (91.4 mg, 0.187 
mmol), and a catalytic amount of anhydrous potassium carbonate in dry methanol (5 
cm^) was stirred at room temperature for 4 h. Concentration of the solvent followed by 
flash chromatography [hexane-diethyl ether (3:2 v/v)] gave the title compound 90 
(76.1 mg, 91%) as a white solid, m.p. 50~52 °C; R^ 0.36 [hexane-diethyl ether (1:1 
v/v)] (Found: C, 75.25; H, 6.6. C28H30O5 requires C, 75.3; H, 6.8%); [a l^^^ + 
30.2 {c 1.2); Vn,a^(film)/cm-l 3450 (OH); 2.25 ( IH, ddd, J 8.8，5.4 and 3.6)，2.80 
( IH , d, J 2.8), 3.19 ( IH, d, J 3.5), 3.33 ( IH, t, J 3.1)，3.51 ( IH, dd, J 9.2 and 5.6), 
3.56 ( IH , d，J 3.5)，3.62 ( IH, dd, J 10.1 and 3.2)，3.71 ( IH , dd, J 9.9 and 8.6)， 
4.40-4.45 ( IH, m), 4.40 and 4.48 (2H, ABq, J 12.2)，4.42 and 4.81 (2H, ABq, J 
11.1), 4.62 and 4.71 (2H, ABq, J 11.5), 7.18-7.35 (15H, m); m/z (EI) 355 ( M + -
C7H7, 13%), 91 (100). 
Method B. To a solution of the epoxide 93 (12.1 mg, 0.0216 mmol) in dry THF 
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(2 cm勺 was added tetxabutylammonium fluoride (1.0 M solution in THF, 0.026 cm^, 
0.024 mmol). The mixture was stirred at room temperature for 3 h. Concentration of 
the solvent followed by flash chromatography [hexane-diethyl ether (1:1 v/v)] afforded 
the title compound 90 (9.1 mg, 94%) as a white solid. 
(lR，2S，3R，4S)-2，3-D/-0-办它 忍 打 
cyclohexen-lX^-triol 91.—A solution of the allylic alcohol 54 (247.4 mg, 0.575 
mmol), imidazole (157 mg, 2.30 mmol), TBDMSCl (173 mg, 1.15 mmol), and a 
catalytic amount of DMAP in dry DMF (6 cm^) was stirred at room temperature for 14 
h. Water (5 cm^) and diethyl ether (5 cm^) were added and the aqueous phase was 
extracted with diethyl ether ( 3 x 6 cm^). The combined organic extracts were washed 
with brine ( 2 x 6 cm^), dried (MgSO*) and filtered. Concentration of the filtrate 
followed by flash chromatography [hexane-diethyl ether (12:1 v/v)] provided the title 
compound 91 (302.2 mg, 96%) as a colourless oil; Rf 0.42 [hexane-diethyl ether 
(10:1 v/v)] (Found: C, 74.9; H, 8.2. €3411440451 requires C, 75.0; H, 8.1%); [a j^^^ 
- 1 . 3 (c 1.5); Vmax(film)/cm-l 3000-3100 (aromatic C -H ) ; 0.06 (3H, s, SiMe), 
0.09 (3H，s, SiMe\ 0.91 (9H，s,⑴w), 2.46 ( IH, m), 3.42 ( IH , dd, J 8.93 and 6.6)， 
3.56-3.63 (2H, m), 3.88 ( IH , dd, J 8.45 and 7.0), 4.41-4.44 (3H，m), 4.52 and 
4.80 (2H，ABq, J 11.5), 4.63 and 4.73 (2H, ABq, J 12.1), 5.71 (2H, br d, J 2.0)， 
7.21-7.36 (15H, m); m/z (EI) 453 (M+ - C7H7, 2%), 438 (M+ - C7H6O, 3), 91 
(100). 
(lR;2R，3S，4R，5R，6R)-and(lS，2R，3S,4R，5R，6S)-3，4-D/-0-6€;2z>^ /-5-Z?enz>^ /oA}7n^ r/iy/-
2-0-ten-lmtyldimethylsilyl-7-oxabicyclolA丄Q]hepuine-2，3A-triol 92 and 93.—To a 
solution of the alkene 91 (58.6 mg, 0.107 mmol) in CH2CI2 (6 cm^) was added 
MCPBA (56 mg, 0.323 mmol) at room temperature. The mixture was heated under 
reflux for 9 h and poured into an aqueous solution of NaOH (0.75 M, 2 cm^). The 
aqueous phase was extracted with CH2CI2 ( 2 x 4 cm^). The combined organic extracts 
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were washed with brine ( 2 x 3 cm^), dried (MgSC^) and filtered. Concentration of the 
filtrate followed by flash chromatography [hexane-diethyl ether (8:1 v/v) followed by 
hexane-diethyl ether (5:1 v/v)] gave initially the title compound 93 (30.8 mg, 51.2%) 
which was followed by 92 (9.6 mg, 15.9%), both as colourless oils. Compound 92; 
Rf 0.24 [hexane-diethyl ether (5:1 v/v)] (Found: C, 72.3; H, 8.0. €3411440551 
requires C, 72.8; H，7.9%); _ 1.9 (〔 i.i)； 3000-3100 
(aromatic C-H) ; 5H 0.12 (3H，s，SiMe), 0.14 (3H, s, SiMe), 1.00 (9H, s，屯u), 2.33 
(IH，m), 3.24 ( IH , t, J 3.8)，3.40-3.55 (3H, m), 3.64-3.76 (2H, m), 4.40 and 4.59 
(2H，ABq, J 11.6), 4.40 ( IH, t’ J 4.2)，4.47 and 4.59 (2H, ABq, J 11.9)，4.53 and 
4.69 (2H, ABq, J 12.2), 7.15-7.35 (15H，m); m/z (EI) 469 (M+ - C7H7, 11%), 91 
(100). 
Compound 93; R^ 0.36 [hexane-diethyl ether (7:1 v/v)] (Found: C, 72.5; H，7.9. 
C34H4405Si requires C, 72.8; H, 7.9%); [a]^^^ + 11 (c 1.1); 3000-
3100 (aromatic C-H); 5H 0.07 (3H, s, SiMe\ 0.10 (3H，s, SiM^), 0.93 (9H，s,屯u), 
2.26 ( IH , m), 3.15 ( IH , dd, J 3.5 and 3.0), 3,20 ( IH, d，J 3.5), 3.47 ( IH, dd, J 93 
and 6.4)，3.52-3.61(2H, m), 3.77 ( IH, dd, J 9.9 and 8.8)，4.35 and 4.45 (2H, ABq, 
J 12), 4.43 and 4.80 (2H, ABq, J 11.3)，4.50 ( IH, t, J 2,6), 4.67 (2H, br s), 7.17-
7.36 (15H, m); m/z (EI) 469 (M+ - C7H7, 11%), 91 (100). 
(1R’2R，3S，4R，5R，6R)-23，4-rh-a_/-5-^rer6a::y/72^%/-7-cw:aZ»'od(9[4.1 
2,3A-triol 9 4 . ~ A solution of the epoxide 3 (18.2 mg, 0.103 mmol), acetic anhydride 
(0.4 cm3)，and a crystal of DMAP in pyridine (2 cm^) was stirred at room temperature 
for 19 h. The solution was diluted with CH2CI2 (5 cm^) and an aqueous saturated 
solution of NH4CI (2 cm3) was added. The aqueous phase was extracted with CH2CI2 
( 4 x 5 cm3) and the combined organic extracts were washed with brine ( 2 x 5 cm^), 
dried (MgS04)，and filtered. Concentration of the filtrate fol lwed by flash 
chromatography [hexane-diethyl ether (2:5 v/v)] gave the tetraacetate 94 (32.3 mg, 
91%) as colourless needles, m.p. 111.5~113 Rf 0.37 [hexane-diethyl ether (1:3 
72 
v/v)] (Found C, 52.4; H, 5.85. C15H20O9 requires C, 52.3; H, 5.85%); [aJo^^ 一 
55.3 (c 0.4); Vmax(film)/cm-l 1744 (C=0); 2.02 (3H, s, Ac), 2.06 (3H, s, Ac), 
2.10 (3H，s，Ac), 2.15 (3H, s，Ac), 2.47 ( IH , m, 5-H), 3.44 ( IH, dd，J 2.5 and 3.8， 
6-H)，3.48 (IH，dd, J 3.8 and 4.1，1-H), 4.25 ( IH , dd，J 7.6 and 11.2，8-H), 4.29 
( I H ’ dd, J 5.5 and 11.2, 8'-H), 4.98 ( IH , dd, J 5.3 and 9.3, 3-H), 5.14 ( IH, dd, J 
7.9 and 9.3, 4-H)，5,51 (IH，t, J 4.8，2-H); 5c 20.4，20.5, 20.6，20.7, 40.0, 50.8, 
53.7，62.5，66.0，66.3，69.2, 169.4，169.7，170.2, 170.5; m/z (EI) 345 (MH+，68%), 
182 (100). 
(IS ,2R,3S,4R,5R,6S)-2,3 ,A^Tri-0~acetyl-5-acetoxymethyn _axabicycb[A. 1.0]heptane-
2,3A-triol 9 5 . A solution of the epoxide 4 (15.8 mg, 0.090 mmol), acetic anhydride 
(0.3 cm3)，and a crystal of DMAP in pyridine (1.5 cm^) was stirred at room 
temperature for 17 h. The solution was diluted with CH2CI2 (4 cm^) and an aqueous 
saturated solution of NH4CI (2 cm^) was added. The aqueous phase was extracted 
with CH2CI2 ( 4 x 4 cm^) and the combined organic extracts were washed with brine 
( 2 x 4 cm3)，dried (MgSO^), and filtered. Concentration of the filtrate foUwed by flash 
chromatography [hexane-diethyl ether (1:2 v/v)] gave the tetraacetate 95 (28.8 mg, 
93%) as a white solid, m.p. 74—75。C; Rf 0.46 [hexane-diethyl ether (1:3 v/v)] 
(Found C, 52.35; H, 5.8. C15H20O9 requires C, 52.3; H，5.85%); [ a ^ ^ ^ 0 (c 0.4); 
Vmax(film)/cm-l 1747 ( O O ) ; 5h 1.92 (3H, s, Ac), 1.98 (3H, s, Ac), 2.05 (3H, s, 
Ac), 2.11 (3H, s，Ac), 2.46 ( IH , m, 5-H), 3.13 ( IH , d，J 3.2，6-H), 3.26 ( IH, t, J 
3.2, 1-H), 4.09 ( IH , dd, J 6.8 and 11.5, 8-H), 4.22 ( IH, dd, J 4.1 and 11.5, 8'-H), 
5.08 ( IH , dd, J 3.0 and 10.7，3-H), 5.18 ( IH, dd, J 8.5 and 10.7，4-H), 5.71 ( IH, t, 
J 3.0, 2-H); 5c 20.4 (x 2), 20.6 (x 2)，40.5, 52.9 (x 2)，62.6, 65.9, 67.2, 69.1， 
169.4，169.7，169.9，170.4; m/z (EI) 345 (MH+，20%), 182 (100). 
73 
(lR，2S，3S，4R，5R)-5-/z:yiir6>;r;ymer/z:y/-7-(9;ca^ic:yd0[4.1.O]/i^pizn^-3，4-di(9/ 
104.~To a suspension of palladium-on-charcoal (25 mg, 5% w/w) in absolute EtOH 
(1.5 cm ) under H2 at atmospheric pressure was added a solution of the compound 
106 (208 mg, 0.484 mmol) in absolute EtOH (10 cm^). The suspension was stirred 
for 6 h at room temperature and filtered through a pad of Celite. The residue was 
washed with methanol (15 cm^). Concentration of the filtrate followed by flash 
chromatography [chloroform—methanol (5:1 v/v)] gave the title compound 104 as 
colourless needles, m . p . 125.5—127 (MeOH); Rf 0.45 [chloroform-methanol (4:1 
v/v)] (Found: C, 52.2; H, 7.6. C7H12O4 requires C, 52.5; H, 7.55%); - 2 (c 
0.5，H2O); Vmax(KBr)/cm-l 3400 (OH); 5 h (D2O) 1.70-1.82 (2H, m), 2 .12-2.22 
( IH , m), 3.40-3.51 (3H, m)，3.56 ( IH , dd, J 11.3 and 5.5, 8-H), 3.64 ( IH, dd, J, 
11.3 and 3.4，8'-H), 3.98 ( IH , dd, J 8.6 and 1.4); 5c (D2O) 26.6, 41.2, 55.6, 58.9, 
62.9, 71.5，74.1; mIz (CI) 161 (MH+，30%). 
(lS，2R，3S，4R，5R)-5-;zy^ir7>x;ym^/i:y/-7-c?jca&ic:ydo[4.1.0]/z€/7ii^-3，4-dib/ 
105.~~To a suspension of palladium-on-charcoal (55 mg, 5% w/w) in absolute EtOH 
(1.5 cm^) under H2 at atmospheric pressure was added a solution of the compound 
110 (313.8 mg, 0.730 mmol) in absolute EtOH (12 cm^). The suspension was stirred 
for 5 h at room temperature and filtered through a pad of Celite. The residue was 
washed with methanol (20 cm^). Concentration of the filtrate followed by flash 
chromatography [chloroform-methanol (5.5:1 v/v)] gave the title compound 105 as a 
colourless oi l which solidify at low temperature; R^ 0.34 [chloroform-methanol (5:1 
v/v)] (Found: C，52.3; H, 7.5. C7H12O4 requires C, 52.5; H, 7.55%); [afe^^ + 37.1 
(c 0.6, H2O); Vmax(KBr)/cm-l 3400 (OH); (D2O) 1.53 ( IH , m, 4-H), 1.81 (IH， 
ddd J 13.7，12.2 and 1.6)，2.26 ( IH , dt, J 15 and 2.1), 3.21 ( IH, d, J 3.93)，3.25 
( IH , dd, J 11.3 and 8.55, 8-H), 3.44 ( IH , br d, J 1.8), 3.65-3.71 (3H, m); 8c 
(D2O) 27.3，35.3, 54.9, 57.6, 62.8, 72.8, 74.1; m/z (CI) 161 (MH+, 92%). 
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(lR，2R，3S，4R，5R)-3,4-Z)i'-0-Z?e«z};/-5-^en2};/o;c}w&/z:y/-l，2-^(9;c};-c3;c/o/2exflA2-
^ A - d i o l 106.一To a solution of the iodo alcohol 71 (116 mg, 0.208 mmol) in 
anhydrous methanol (5 cm^) was added sodium methoxide (12.4 mg, 0.229 mmol) at 
room temperature and the suspension was stirred for 5 min. The mixture was then 
filtered through a pad of silica gel topped with Celite and washed with CH2CI2 (10 
cm"^). Concentration of the filtrate followed by flash chromatography [hexane-diethyl 
ether (3:1 v/v)] afforded the title compound 106 ( 85.1 mg, 95%) as colourless 
needles，m.p. 60—62。C; i?f0.56 [hexane-ethyl acetate (3:1 v/v)]; [aJo^l + 29.3 (c 
1-23)； Vmax(film)/cm] 3000-3100 (aromatic C-H); 5H 1.76-2.16 (3H, m), 3.25 ( IH, 
t，J 4.0), 3.33 ( IH, dd, J 4.0 and 1.8)，3.48 (2H, m), 3.65 ( IH, dd, J 10.8 and 8.1), 
3.83 ( IH , dd, J 8.1 and 1.9)，4.45 (2H, s), 4.52 and 4.84 (2H, ABq, J 10.8)，4.82 
(2H, s)，7,22-7.43 (15H, m); m/z (EI) 339 (M+ - C7H7, 6%), 91 (100). 
(lR，2R，3R，4R，6R)-2，3-D/-0-ac 已 似 印 如 
2,3-diol 107.—A solution of the epoxide 104 (14.1 mg, 0.088 mmol), acetic 
anhydride (0.3 cm^), and a crystal of DMAP in pyridine (2 cm^) was stirred at room 
temperature for 15 h。The solution was diluted with CH2CI2 (5 cm^) and an aqueous 
saturated solution of NH4CI (2 cm^) was added. The aqueous phase was extracted 
with CH2CI2 ( 4 x 5 cm3) and the combined organic extracts were washed with brine 
( 2 x 5 cm^), dried (MgS04)，肌 d filtered. Concentration of the filtrate foil wed by flash 
chromatography [hexane-diethyl ether (3:4 v/v)] gave the triacetate 107 (19.0 mg, 
75%) as a colourless oil; R^ 0.25 [hexane-diethyl ether (2:3 v/v)] (Found C, 54.3; H, 
6.4. C13H18O7 requires C, 54.5; H, 6.3%); [a j^^^ 一 9 5 0.7); 
1743 (C=0); 5H 1.89-2.16 (3H, m), 1.95 (3H, s), 1.97 (3H, s), 2.04 (3H, s)，3.27 
( IH, dd, J 4.4 and 4.3) and 3.35 ( IH, dd, 7, 3.95 and 1.75), 3.79 ( IH, dd，J 11.3 
and 3.1), 3.99 ( IH, dd, J 11.3 and 4.8)，5.07 ( IH, dd, J 10.2 and 8.8), 5.17 ( IH, dd, 
J 8.8 and 1.8); 5c 20.6 (x 2), 20.7, 26.3, 37.5, 52.6, 54.5, 63.2, 69.6，73.4，169.7， 
170.6 (X 2); m/z (EI) 244 (M+ - C2H2O, 23%), 43 (100). 
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(lR，2R’3S’4R，5R)-3，4-D/。_Z?e/iz:y/-5-6e"z:yi(9;c;ywer/2:v/-l，2-r/zf(9az^o"^3fe-
cyclohexan-lX'^A'tetrol 108.—To a solution of the diol 57 (109.7 mg, 0.245 mmol) 
in toluene (5 cm3) was added 1,1thiocarbonyIdiimidazole (131 mg, 0.735 mmol) at 
room temperature. The mixture was heated under reflux for 24 h and poured into H〗。 
(2 cm-^). The aqueous layer was extracted with diethyl ethyl ( 3 x 2 cm^). The 
combined organic extracts were washed with brine ( 2 x 2 cm^), dried (MgS04) and 
filtered. Concentration of the filtrate followed by flash chromatography [hexane— 
diethyl ether (5:4 v/v)] afforded the title compound 108 (103.3 mg, 86%) as a 
colourless oil; /?f0.31 [hexane-diethyl ether (1:1 v/v)] (Found: C, 71.0; H, 6.2. 
C29H30O5S requires C, 71.0; H, 6.2%); [aJo^l 一 27.3 {c 1.1); Vmax(film)/cm-l 1350 
(C=S); 5H 1.90-2.16 (2H, m), 1.56-1.70 ( IH, m), 3.23-3.35 (2H, m), 3.52 ( IH, 
dd, J 6.7 and 3.7), 3.75 ( IH, t, J 3.5), 4.20 and 4.35 (2H, ABq, J 11.6)，4.33 (2H, 
s)，4.45 and 4.63 (2H, ABq, J 12.0)，4.88-4.96 (2H, m), 7.03-7.29 (15H，m); m/z 
(EI) 399 (M+-C7H7, 4%), 91 (100). 
(lR，2R，3R)-l’2-Z)/-0-be"z>^/-3-Z?e«z7/ai}ww/2:y/-5-c:vc/(9/zae-l，2-^//o/109.—To 
a solution of the diol 57 (1 g, 2.23 mmol) in toluene (50 cm^) was added 1,1'-
thiocarbonyldiimidazole (1.2 g, 6.70 mmol). The mixture was heated for 6 hat 100 °C 
and poured into water (25 cm 3). The aqueous layer was extracted with diether ether (4 
X 25 cm3). The combined extracts were washed with brine (2 x 15 cm^), dried 
(MgS04) and filtered. Concentration of the filtrate provided a yellow oil 108. 
The oil 108 was dissolved in trimethylphosphite (50 cnP) and the solution was 
heated for 3 d at 120 °C. Removal of the solvent under reduced pressure followed by 
flash chromatography [hexane-diethyl ether (7:1 v/v)] provided the title compound 
109 (0.65 g, 70%) as a colourless oil; Rf 0.50 [hexane-diethyl ether (5:1 v/v)] 
(Found: C, 81.15; H, 7.4. C28H30O3 requires C, 81.1; H, 7.3%); [ a b ^ ^ + 2.4 (c 
1.2); Vmax(film)/cm-l 1650 (C=C); 5h 2.01-2.20 (3H, m), 3.58 ( IH, dd, J 9.0 and 
3.1)，3.64-3.74 (2H, m), 4.18 ( IH, dd, J 5.0 and 2.1), 4.18 (2H, br s), 4.65 and 
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4.70 (2H, ABq, J 11.8)，4.88 and 5.62 (2H, ABq, J 11.0), 5.67 ( IH, dd，J 10.2 and 
1.23), 5.76 (IH，br d, J 11.0)，7.22-7.37 (15H, m); m/z (EI) 323 ( M + - C7H7， 
1.4%)，217 (M+ - C7H7 - C7H5O, 5), 91 (100). 
(lS,2S,3S,4R,5R)-3 A-Di-0-be nzyl- 5 -benzyloxymethyl-1,2-epoxy-cy clohexan-
^A-diol 110.~To a solution of the alkene 109 (117 mg, 0.282 mmol) in CH2CI2 (10 
cm3) was added MCPBA (102 mg, 0.56 mmol). The mixture was stirred at room 
temperature for 24 h and poured into an aqueous solution of NaOH (1 M, 10 cnP). 
The aqueous phase was extracted with CH2CI2 (2 x 10 cm^). The combined extracts 
were washed with NH4CI ( 2 x 4 cm^), brine ( 2 x 4 cm^), dried (MgS04) and filtered 
Concentration of the filtrate followed by flash chromatography [hexane-diethyl ether 
(4:1 v/v)] gave 110 (82.2 mg, 68%) and then 106 (20.5 mg, 17%), both as white 
solids. Compound 110; m.p. 32—34 Rf 0.36 [hexane-diethyl ether (3:1 v/v)] 
(Found: C, 77.8; H，7.1. C28H30O4 requires C，78.1; H, 7.0%); [a fo^ l + 18.2 (c 
I.1)； Vmax(film)/cm-l 3000-3100 (aromatic C-H); 5h 1.80 ( IH, m), 2.07 ( IH, dt, J 
I I .8 and 1.5), 2.23 ( IH, ddd, J 15, 4.4 and 1.8), 3.15 ( IH, d, J 3.7)，3.23 ( IH, m), 
3.40 (IH，dd, J 8.9 and 2.6), 3.44 ( IH, dd, J 11.3 and 8.0)，3.72 ( IH, dd, J 9.0 and 
4.5), 3.78 ( IH, d, J 8.0)，4.45 (2H, br s), 4.69 and 4.80 (2H, ABq, J 11.4), 4.56 and 
4.84 (2H, ABq, J 11.0), 7.20-7.36 (15H, m); m/z (EI) 339 (M+ - C7H7, 31%), 91 
(100). 
(1S，2R，3R，4R,6S)-2,3-Di-0-acetyl-4-acetoxymethyl-l-oxabicyclo[4.1.0]heptane-
2,3-diol 111.—A solution of the epoxide 105 (12.5 mg, 0.078 mmol), acetic 
anhydride (0.3 cm^), and a crystal of DMAP in pyridine (2 cm^) was stirred at room 
temperature for 12 h. The solution was diluted with CH2CI2 (5 cm^) and an aqueous 
saturated solution of NH4CI (2 cm^) was added. The aqueous phase was extracted 
with CH2CI2 ( 4 x 5 cm3) and the combined organic extracts were washed with brine 
( 2 x 5 cm3)’ dried (MgS04)，and filtered. Concentration of the filtrate foUwed by flash 
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chromatography [hexane-diethyl ether (2:3 v/v)] gave the triacetate 111 (18.2 mg, 
81%) as a white solid，m .p. 59—61。C;及f 0.35 [hexane-diethyl ether (2:3 v/v)] 
(Found C’ 54.4; H, 6.4. C13H18O7 requires C, 54.5; H, 6.3%); + 41.7 (c 
0.5); Vmax(film)/cm-l 1742 (C=0); 5h 1.98—2.11 (2H, m), 2.03 (3H, s), 2.04 (3H, 
s)，2.08 (3H, s), 2.32 ( IH , m), 3.08 ( IH, dd, J 3.6 and 0.5), 3.32 ( IH, br d, J 2.4), 
3.84 ( IH , dd, J 11.3 and 2.5, 8-H), 4.20 ( IH, dd, J 11.3 and 3.95, 8,-H)，4.91-5.03 
(2H，m); 5c 20.45, 20.5, 20.6’ 27.2，31.1，52.2, 54.0, 62.8，71.0，71.9，169.8， 
170.0，170.4; m/z (EI) 243 (M+ - C2H3O, 55%), 124 (100). 
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